id	sid	tid	token	lemma	pos
dpc-826	1	1	untitled	untitled	ADJ
dpc-826	1	2	observation	observation	NOUN
dpc-826	1	3	|	|	INTJ
dpc-826	1	4	dermatol	dermatol	NOUN
dpc-826	1	5	pract	pract	NOUN
dpc-826	1	6	concept	concept	NOUN
dpc-826	1	7	2015;5(2):24	2015;5(2):24	NUM
dpc-826	1	8	121	121	NUM
dpc-826	1	9	dermatology	dermatology	NOUN
dpc-826	1	10	practical	practical	ADJ
dpc-826	1	11	&	&	CCONJ
dpc-826	1	12	conceptual	conceptual	ADJ
dpc-826	1	13	www.derm101.com	www.derm101.com	X
dpc-826	1	14	nab	nab	NOUN
dpc-826	1	15	-	-	PUNCT
dpc-826	1	16	paclitaxel	paclitaxel	NOUN
dpc-826	1	17	-	-	PUNCT
dpc-826	1	18	associated	associate	VERB
dpc-826	1	19	photosensitivity	photosensitivity	NOUN
dpc-826	1	20	:	:	PUNCT
dpc-826	1	21	report	report	NOUN
dpc-826	1	22	in	in	ADP
dpc-826	1	23	a	a	DET
dpc-826	1	24	woman	woman	NOUN
dpc-826	1	25	with	with	ADP
dpc-826	1	26	non	non	ADJ
dpc-826	1	27	-	-	ADJ
dpc-826	1	28	small	small	ADJ
dpc-826	1	29	cell	cell	NOUN
dpc-826	1	30	lung	lung	NOUN
dpc-826	1	31	cancer	cancer	NOUN
dpc-826	1	32	and	and	CCONJ
dpc-826	1	33	review	review	NOUN
dpc-826	1	34	of	of	ADP
dpc-826	1	35	taxane	taxane	NOUN
dpc-826	1	36	-	-	PUNCT
dpc-826	1	37	related	relate	VERB
dpc-826	1	38	photodermatoses	photodermatose	NOUN
dpc-826	1	39	bryce	bryce	PROPN
dpc-826	1	40	d.	d.	PROPN
dpc-826	1	41	beutler1	beutler1	PROPN
dpc-826	1	42	,	,	PUNCT
dpc-826	1	43	philip	philip	PROPN
dpc-826	1	44	r.	r.	PROPN
dpc-826	1	45	cohen2	cohen2	PROPN
dpc-826	1	46	1	1	NUM
dpc-826	1	47	university	university	PROPN
dpc-826	1	48	of	of	ADP
dpc-826	1	49	nevada	nevada	PROPN
dpc-826	1	50	,	,	PUNCT
dpc-826	1	51	las	las	PROPN
dpc-826	1	52	vegas	vegas	PROPN
dpc-826	1	53	,	,	PUNCT
dpc-826	1	54	school	school	NOUN
dpc-826	1	55	of	of	ADP
dpc-826	1	56	allied	ally	VERB
dpc-826	1	57	health	health	NOUN
dpc-826	1	58	sciences	sciences	PROPN
dpc-826	1	59	,	,	PUNCT
dpc-826	1	60	las	las	PROPN
dpc-826	1	61	vegas	vegas	PROPN
dpc-826	1	62	,	,	PUNCT
dpc-826	1	63	nv	nv	PROPN
dpc-826	1	64	,	,	PUNCT
dpc-826	1	65	usa	usa	PROPN
dpc-826	1	66	2	2	NUM
dpc-826	1	67	department	department	NOUN
dpc-826	1	68	of	of	ADP
dpc-826	1	69	dermatology	dermatology	NOUN
dpc-826	1	70	,	,	PUNCT
dpc-826	1	71	university	university	PROPN
dpc-826	1	72	of	of	ADP
dpc-826	1	73	california	california	PROPN
dpc-826	1	74	san	san	PROPN
dpc-826	1	75	diego	diego	PROPN
dpc-826	1	76	,	,	PUNCT
dpc-826	1	77	san	san	PROPN
dpc-826	1	78	diego	diego	PROPN
dpc-826	1	79	,	,	PUNCT
dpc-826	1	80	ca	ca	PROPN
dpc-826	1	81	,	,	PUNCT
dpc-826	1	82	usa	usa	PROPN
dpc-826	1	83	key	key	NOUN
dpc-826	1	84	words	word	NOUN
dpc-826	1	85	:	:	PUNCT
dpc-826	1	86	abraxane	abraxane	ADJ
dpc-826	1	87	,	,	PUNCT
dpc-826	1	88	albumin	albumin	NOUN
dpc-826	1	89	,	,	PUNCT
dpc-826	1	90	cremophor	cremophor	NOUN
dpc-826	1	91	,	,	PUNCT
dpc-826	1	92	docetaxel	docetaxel	PROPN
dpc-826	1	93	,	,	PUNCT
dpc-826	1	94	kolliphor	kolliphor	PROPN
dpc-826	1	95	,	,	PUNCT
dpc-826	1	96	nab	nab	NOUN
dpc-826	1	97	-	-	PUNCT
dpc-826	1	98	paclitaxel	paclitaxel	NOUN
dpc-826	1	99	,	,	PUNCT
dpc-826	1	100	paclitaxel	paclitaxel	PROPN
dpc-826	1	101	,	,	PUNCT
dpc-826	1	102	photodermatoses	photodermatose	NOUN
dpc-826	1	103	,	,	PUNCT
dpc-826	1	104	photosensitvity	photosensitvity	NOUN
dpc-826	1	105	,	,	PUNCT
dpc-826	1	106	taxane	taxane	NOUN
dpc-826	1	107	citation	citation	NOUN
dpc-826	1	108	:	:	PUNCT
dpc-826	1	109	beutler	beutler	PROPN
dpc-826	1	110	bd	bd	PROPN
dpc-826	1	111	,	,	PUNCT
dpc-826	1	112	cohen	cohen	PROPN
dpc-826	1	113	pr	pr	PROPN
dpc-826	1	114	.	.	PUNCT
dpc-826	2	1	nab	nab	PROPN
dpc-826	2	2	-	-	PUNCT
dpc-826	2	3	paclitaxel	paclitaxel	NOUN
dpc-826	2	4	-	-	PUNCT
dpc-826	2	5	associated	associate	VERB
dpc-826	2	6	photosensitivity	photosensitivity	NOUN
dpc-826	2	7	:	:	PUNCT
dpc-826	2	8	report	report	NOUN
dpc-826	2	9	in	in	ADP
dpc-826	2	10	a	a	DET
dpc-826	2	11	woman	woman	NOUN
dpc-826	2	12	with	with	ADP
dpc-826	2	13	non	non	ADJ
dpc-826	2	14	-	-	ADJ
dpc-826	2	15	small	small	ADJ
dpc-826	2	16	cell	cell	NOUN
dpc-826	2	17	lung	lung	NOUN
dpc-826	2	18	cancer	cancer	NOUN
dpc-826	2	19	and	and	CCONJ
dpc-826	2	20	review	review	NOUN
dpc-826	2	21	of	of	ADP
dpc-826	2	22	taxane	taxane	NOUN
dpc-826	2	23	-	-	PUNCT
dpc-826	2	24	related	relate	VERB
dpc-826	2	25	photodermatoses	photodermatose	NOUN
dpc-826	2	26	.	.	PUNCT
dpc-826	3	1	dermatol	dermatol	NOUN
dpc-826	3	2	pract	pract	PROPN
dpc-826	3	3	concept	concept	NOUN
dpc-826	3	4	2015;5(2):24	2015;5(2):24	NUM
dpc-826	3	5	.	.	PUNCT
dpc-826	3	6	doi	doi	NOUN
dpc-826	3	7	:	:	PUNCT
dpc-826	3	8	10.5826	10.5826	NUM
dpc-826	3	9	/	/	SYM
dpc-826	4	1	dpc.0502a24	dpc.0502a24	PROPN
dpc-826	4	2	received	receive	VERB
dpc-826	4	3	:	:	PUNCT
dpc-826	4	4	january	january	PROPN
dpc-826	4	5	12	12	NUM
dpc-826	4	6	,	,	PUNCT
dpc-826	4	7	2015	2015	NUM
dpc-826	4	8	;	;	PUNCT
dpc-826	4	9	accepted	accept	VERB
dpc-826	4	10	:	:	PUNCT
dpc-826	4	11	march	march	PROPN
dpc-826	4	12	16	16	NUM
dpc-826	4	13	,	,	PUNCT
dpc-826	4	14	2015	2015	NUM
dpc-826	4	15	;	;	PUNCT
dpc-826	4	16	published	publish	VERB
dpc-826	4	17	:	:	PUNCT
dpc-826	4	18	april	april	PROPN
dpc-826	4	19	30	30	NUM
dpc-826	4	20	,	,	PUNCT
dpc-826	4	21	2015	2015	NUM
dpc-826	4	22	copyright	copyright	NOUN
dpc-826	4	23	:	:	PUNCT
dpc-826	4	24	©	©	PROPN
dpc-826	4	25	2015	2015	NUM
dpc-826	4	26	beutler	beutler	NOUN
dpc-826	4	27	et	et	PROPN
dpc-826	4	28	al	al	PROPN
dpc-826	4	29	.	.	PUNCT
dpc-826	5	1	this	this	PRON
dpc-826	5	2	is	be	AUX
dpc-826	5	3	an	an	DET
dpc-826	5	4	open	open	ADJ
dpc-826	5	5	-	-	PUNCT
dpc-826	5	6	access	access	NOUN
dpc-826	5	7	article	article	NOUN
dpc-826	5	8	distributed	distribute	VERB
dpc-826	5	9	under	under	ADP
dpc-826	5	10	the	the	DET
dpc-826	5	11	terms	term	NOUN
dpc-826	5	12	of	of	ADP
dpc-826	5	13	the	the	DET
dpc-826	5	14	creative	creative	ADJ
dpc-826	5	15	commons	common	NOUN
dpc-826	5	16	attribution	attribution	NOUN
dpc-826	5	17	license	license	NOUN
dpc-826	5	18	,	,	PUNCT
dpc-826	5	19	which	which	PRON
dpc-826	5	20	permits	permit	VERB
dpc-826	5	21	unrestricted	unrestricted	ADJ
dpc-826	5	22	use	use	NOUN
dpc-826	5	23	,	,	PUNCT
dpc-826	5	24	distribution	distribution	NOUN
dpc-826	5	25	,	,	PUNCT
dpc-826	5	26	and	and	CCONJ
dpc-826	5	27	reproduction	reproduction	NOUN
dpc-826	5	28	in	in	ADP
dpc-826	5	29	any	any	DET
dpc-826	5	30	medium	medium	NOUN
dpc-826	5	31	,	,	PUNCT
dpc-826	5	32	provided	provide	VERB
dpc-826	5	33	the	the	DET
dpc-826	5	34	original	original	ADJ
dpc-826	5	35	author	author	NOUN
dpc-826	5	36	and	and	CCONJ
dpc-826	5	37	source	source	NOUN
dpc-826	5	38	are	be	AUX
dpc-826	5	39	credited	credit	VERB
dpc-826	5	40	.	.	PUNCT
dpc-826	6	1	funding	funding	NOUN
dpc-826	6	2	:	:	PUNCT
dpc-826	6	3	none	none	NOUN
dpc-826	6	4	.	.	PUNCT
dpc-826	7	1	competing	compete	VERB
dpc-826	7	2	interests	interest	NOUN
dpc-826	7	3	:	:	PUNCT
dpc-826	7	4	the	the	DET
dpc-826	7	5	authors	author	NOUN
dpc-826	7	6	have	have	VERB
dpc-826	7	7	no	no	DET
dpc-826	7	8	conflicts	conflict	NOUN
dpc-826	7	9	of	of	ADP
dpc-826	7	10	interest	interest	NOUN
dpc-826	7	11	to	to	PART
dpc-826	7	12	disclose	disclose	VERB
dpc-826	7	13	.	.	PUNCT
dpc-826	8	1	all	all	DET
dpc-826	8	2	authors	author	NOUN
dpc-826	8	3	have	have	AUX
dpc-826	8	4	contributed	contribute	VERB
dpc-826	8	5	significantly	significantly	ADV
dpc-826	8	6	to	to	ADP
dpc-826	8	7	this	this	DET
dpc-826	8	8	publication	publication	NOUN
dpc-826	8	9	.	.	PUNCT
dpc-826	9	1	corresponding	correspond	VERB
dpc-826	9	2	author	author	NOUN
dpc-826	9	3	:	:	PUNCT
dpc-826	9	4	philip	philip	PROPN
dpc-826	9	5	r.	r.	PROPN
dpc-826	9	6	cohen	cohen	PROPN
dpc-826	9	7	,	,	PUNCT
dpc-826	9	8	md	md	PROPN
dpc-826	9	9	.	.	PROPN
dpc-826	9	10	email	email	PROPN
dpc-826	9	11	:	:	PUNCT
dpc-826	10	1	mitehead@gmail.com	mitehead@gmail.com	X
dpc-826	10	2	background	background	NOUN
dpc-826	10	3	:	:	PUNCT
dpc-826	10	4	taxanes	taxane	NOUN
dpc-826	11	1	[	[	X
dpc-826	11	2	paclitaxel	paclitaxel	NOUN
dpc-826	11	3	,	,	PUNCT
dpc-826	11	4	nab	nab	NOUN
dpc-826	11	5	-	-	PUNCT
dpc-826	11	6	paclitaxel	paclitaxel	PROPN
dpc-826	11	7	(	(	PUNCT
dpc-826	11	8	abraxane	abraxane	ADJ
dpc-826	11	9	,	,	PUNCT
dpc-826	11	10	celgene	celgene	PROPN
dpc-826	11	11	corp	corp	PROPN
dpc-826	11	12	,	,	PUNCT
dpc-826	11	13	usa	usa	PROPN
dpc-826	11	14	)	)	PUNCT
dpc-826	11	15	,	,	PUNCT
dpc-826	11	16	and	and	CCONJ
dpc-826	11	17	docetaxel	docetaxel	PROPN
dpc-826	11	18	]	]	PUNCT
dpc-826	11	19	—	—	PUNCT
dpc-826	11	20	used	use	VERB
dpc-826	11	21	in	in	ADP
dpc-826	11	22	the	the	DET
dpc-826	11	23	treatment	treatment	NOUN
dpc-826	11	24	of	of	ADP
dpc-826	11	25	lung	lung	NOUN
dpc-826	11	26	,	,	PUNCT
dpc-826	11	27	breast	breast	NOUN
dpc-826	11	28	,	,	PUNCT
dpc-826	11	29	and	and	CCONJ
dpc-826	11	30	head	head	NOUN
dpc-826	11	31	and	and	CCONJ
dpc-826	11	32	neck	neck	NOUN
dpc-826	11	33	cancers	cancer	NOUN
dpc-826	11	34	—	—	PUNCT
dpc-826	11	35	have	have	AUX
dpc-826	11	36	been	be	AUX
dpc-826	11	37	associated	associate	VERB
dpc-826	11	38	with	with	ADP
dpc-826	11	39	cutaneous	cutaneous	ADJ
dpc-826	11	40	adverse	adverse	ADJ
dpc-826	11	41	effects	effect	NOUN
dpc-826	11	42	,	,	PUNCT
dpc-826	11	43	including	include	VERB
dpc-826	11	44	photodermatoses	photodermatose	NOUN
dpc-826	11	45	.	.	PUNCT
dpc-826	12	1	purpose	purpose	NOUN
dpc-826	12	2	:	:	PUNCT
dpc-826	12	3	we	we	PRON
dpc-826	12	4	describe	describe	VERB
dpc-826	12	5	a	a	DET
dpc-826	12	6	woman	woman	NOUN
dpc-826	12	7	with	with	ADP
dpc-826	12	8	non	non	ADJ
dpc-826	12	9	-	-	ADJ
dpc-826	12	10	small	small	ADJ
dpc-826	12	11	cell	cell	NOUN
dpc-826	12	12	lung	lung	NOUN
dpc-826	12	13	cancer	cancer	NOUN
dpc-826	12	14	who	who	PRON
dpc-826	12	15	developed	develop	VERB
dpc-826	12	16	a	a	DET
dpc-826	12	17	photodistributed	photodistribute	VERB
dpc-826	12	18	dermatitis	dermatitis	NOUN
dpc-826	12	19	associated	associate	VERB
dpc-826	12	20	with	with	ADP
dpc-826	12	21	her	her	PRON
dpc-826	12	22	nab	nab	PROPN
dpc-826	12	23	-	-	PUNCT
dpc-826	12	24	paclitaxel	paclitaxel	ADJ
dpc-826	12	25	therapy	therapy	NOUN
dpc-826	12	26	and	and	CCONJ
dpc-826	12	27	review	review	VERB
dpc-826	12	28	photodermatoses	photodermatose	NOUN
dpc-826	12	29	in	in	ADP
dpc-826	12	30	patients	patient	NOUN
dpc-826	12	31	receiving	receive	VERB
dpc-826	12	32	taxanes	taxane	NOUN
dpc-826	12	33	.	.	PUNCT
dpc-826	13	1	materials	material	NOUN
dpc-826	13	2	and	and	CCONJ
dpc-826	13	3	methods	method	NOUN
dpc-826	13	4	:	:	PUNCT
dpc-826	13	5	the	the	DET
dpc-826	13	6	features	feature	NOUN
dpc-826	13	7	of	of	ADP
dpc-826	13	8	a	a	DET
dpc-826	13	9	woman	woman	NOUN
dpc-826	13	10	with	with	ADP
dpc-826	13	11	a	a	DET
dpc-826	13	12	nab	nab	VERB
dpc-826	13	13	-	-	PUNCT
dpc-826	13	14	paclitaxel	paclitaxel	NOUN
dpc-826	13	15	-	-	PUNCT
dpc-826	13	16	associated	associate	VERB
dpc-826	13	17	photodistributed	photodistribute	VERB
dpc-826	13	18	dermatitis	dermatitis	NOUN
dpc-826	13	19	are	be	AUX
dpc-826	13	20	presented	present	VERB
dpc-826	13	21	and	and	CCONJ
dpc-826	13	22	the	the	DET
dpc-826	13	23	literature	literature	NOUN
dpc-826	13	24	on	on	ADP
dpc-826	13	25	nab	nab	NOUN
dpc-826	13	26	-	-	PUNCT
dpc-826	13	27	paclitaxel	paclitaxel	NOUN
dpc-826	13	28	-	-	PUNCT
dpc-826	13	29	associated	associate	VERB
dpc-826	13	30	photosensitivity	photosensitivity	NOUN
dpc-826	13	31	is	be	AUX
dpc-826	13	32	reviewed	review	VERB
dpc-826	13	33	.	.	PUNCT
dpc-826	14	1	results	result	NOUN
dpc-826	14	2	:	:	PUNCT
dpc-826	14	3	our	our	PRON
dpc-826	14	4	patient	patient	NOUN
dpc-826	14	5	developed	develop	VERB
dpc-826	14	6	nab	nab	NOUN
dpc-826	14	7	-	-	PUNCT
dpc-826	14	8	paclitaxel	paclitaxel	NOUN
dpc-826	14	9	-	-	PUNCT
dpc-826	14	10	associated	associate	VERB
dpc-826	14	11	photodistributed	photodistribute	VERB
dpc-826	14	12	dermatitis	dermatitis	NOUN
dpc-826	14	13	on	on	ADP
dpc-826	14	14	the	the	DET
dpc-826	14	15	sun	sun	NOUN
dpc-826	14	16	-	-	PUNCT
dpc-826	14	17	exposed	expose	VERB
dpc-826	14	18	surfaces	surface	NOUN
dpc-826	14	19	of	of	ADP
dpc-826	14	20	her	her	PRON
dpc-826	14	21	upper	upper	ADJ
dpc-826	14	22	extremities	extremity	NOUN
dpc-826	14	23	,	,	PUNCT
dpc-826	14	24	which	which	PRON
dpc-826	14	25	was	be	AUX
dpc-826	14	26	exacerbated	exacerbate	VERB
dpc-826	14	27	with	with	ADP
dpc-826	14	28	each	each	DET
dpc-826	14	29	course	course	NOUN
dpc-826	14	30	of	of	ADP
dpc-826	14	31	nab	nab	NOUN
dpc-826	14	32	-	-	PUNCT
dpc-826	14	33	paclitaxel	paclitaxel	NOUN
dpc-826	14	34	.	.	PUNCT
dpc-826	15	1	biopsies	biopsy	NOUN
dpc-826	15	2	revealed	reveal	VERB
dpc-826	15	3	an	an	DET
dpc-826	15	4	interface	interface	NOUN
dpc-826	15	5	dermatitis	dermatitis	NOUN
dpc-826	15	6	and	and	CCONJ
dpc-826	15	7	laboratory	laboratory	NOUN
dpc-826	15	8	studies	study	NOUN
dpc-826	15	9	were	be	AUX
dpc-826	15	10	negative	negative	ADJ
dpc-826	15	11	for	for	ADP
dpc-826	15	12	lupus	lupus	ADJ
dpc-826	15	13	erythematosus	erythematosus	NOUN
dpc-826	15	14	and	and	CCONJ
dpc-826	15	15	dermatomyositis	dermatomyositis	PROPN
dpc-826	15	16	.	.	PUNCT
dpc-826	16	1	her	her	PRON
dpc-826	16	2	condition	condition	NOUN
dpc-826	16	3	improved	improve	VERB
dpc-826	16	4	following	follow	VERB
dpc-826	16	5	topical	topical	ADJ
dpc-826	16	6	corticosteroid	corticosteroid	ADJ
dpc-826	16	7	cream	cream	NOUN
dpc-826	16	8	application	application	NOUN
dpc-826	16	9	and	and	CCONJ
dpc-826	16	10	strict	strict	ADJ
dpc-826	16	11	avoidance	avoidance	NOUN
dpc-826	16	12	of	of	ADP
dpc-826	16	13	sunlight	sunlight	NOUN
dpc-826	16	14	.	.	PUNCT
dpc-826	17	1	conclusion	conclusion	NOUN
dpc-826	17	2	:	:	PUNCT
dpc-826	17	3	chemotherapy	chemotherapy	NOUN
dpc-826	17	4	can	can	AUX
dpc-826	17	5	be	be	AUX
dpc-826	17	6	associated	associate	VERB
dpc-826	17	7	with	with	ADP
dpc-826	17	8	adverse	adverse	ADJ
dpc-826	17	9	mucocutaneous	mucocutaneous	ADJ
dpc-826	17	10	events	event	NOUN
dpc-826	17	11	,	,	PUNCT
dpc-826	17	12	including	include	VERB
dpc-826	17	13	dermatoses	dermatosis	NOUN
dpc-826	17	14	on	on	ADP
dpc-826	17	15	sun	sun	NOUN
dpc-826	17	16	-	-	PUNCT
dpc-826	17	17	exposed	expose	VERB
dpc-826	17	18	areas	area	NOUN
dpc-826	17	19	of	of	ADP
dpc-826	17	20	the	the	DET
dpc-826	17	21	skin	skin	NOUN
dpc-826	17	22	.	.	PUNCT
dpc-826	18	1	paclitaxel	paclitaxel	PROPN
dpc-826	18	2	and	and	CCONJ
dpc-826	18	3	nab	nab	NOUN
dpc-826	18	4	-	-	PUNCT
dpc-826	18	5	paclitaxel	paclitaxel	PROPN
dpc-826	18	6	have	have	AUX
dpc-826	18	7	both	both	PRON
dpc-826	18	8	been	be	AUX
dpc-826	18	9	associated	associate	VERB
dpc-826	18	10	with	with	ADP
dpc-826	18	11	photodermatoses	photodermatose	NOUN
dpc-826	18	12	,	,	PUNCT
dpc-826	18	13	including	include	VERB
dpc-826	18	14	dermatitis	dermatitis	NOUN
dpc-826	18	15	,	,	PUNCT
dpc-826	18	16	erythema	erythema	ADJ
dpc-826	18	17	multiforme	multiforme	NOUN
dpc-826	18	18	,	,	PUNCT
dpc-826	18	19	onycholysis	onycholysis	NOUN
dpc-826	18	20	,	,	PUNCT
dpc-826	18	21	and	and	CCONJ
dpc-826	18	22	subacute	subacute	VERB
dpc-826	18	23	cutaneous	cutaneous	ADJ
dpc-826	18	24	lupus	lupus	PROPN
dpc-826	18	25	erythematosus	erythematosus	PROPN
dpc-826	18	26	.	.	PUNCT
dpc-826	19	1	strict	strict	ADJ
dpc-826	19	2	avoidance	avoidance	NOUN
dpc-826	19	3	of	of	ADP
dpc-826	19	4	sun	sun	NOUN
dpc-826	19	5	exposure	exposure	NOUN
dpc-826	19	6	,	,	PUNCT
dpc-826	19	7	topical	topical	ADJ
dpc-826	19	8	or	or	CCONJ
dpc-826	19	9	oral	oral	ADJ
dpc-826	19	10	corticosteroids	corticosteroid	NOUN
dpc-826	19	11	,	,	PUNCT
dpc-826	19	12	and/or	and/or	CCONJ
dpc-826	19	13	discontinuation	discontinuation	NOUN
dpc-826	19	14	of	of	ADP
dpc-826	19	15	the	the	DET
dpc-826	19	16	drug	drug	NOUN
dpc-826	19	17	results	result	NOUN
dpc-826	19	18	in	in	ADP
dpc-826	19	19	improvement	improvement	NOUN
dpc-826	19	20	with	with	ADP
dpc-826	19	21	progressive	progressive	ADJ
dpc-826	19	22	resolution	resolution	NOUN
dpc-826	19	23	of	of	ADP
dpc-826	19	24	symptoms	symptom	NOUN
dpc-826	19	25	and	and	CCONJ
dpc-826	19	26	skin	skin	NOUN
dpc-826	19	27	lesions	lesion	NOUN
dpc-826	19	28	.	.	PUNCT
dpc-826	20	1	development	development	NOUN
dpc-826	20	2	of	of	ADP
dpc-826	20	3	photodermatoses	photodermatose	NOUN
dpc-826	20	4	is	be	AUX
dpc-826	20	5	not	not	PART
dpc-826	20	6	an	an	DET
dpc-826	20	7	absolute	absolute	ADJ
dpc-826	20	8	contraindication	contraindication	NOUN
dpc-826	20	9	to	to	ADP
dpc-826	20	10	continuing	continue	VERB
dpc-826	20	11	chemotherapy	chemotherapy	NOUN
dpc-826	20	12	,	,	PUNCT
dpc-826	20	13	provided	provide	VERB
dpc-826	20	14	that	that	SCONJ
dpc-826	20	15	the	the	DET
dpc-826	20	16	cutaneous	cutaneous	ADJ
dpc-826	20	17	condition	condition	NOUN
dpc-826	20	18	resolves	resolve	NOUN
dpc-826	20	19	with	with	ADP
dpc-826	20	20	dermatosis	dermatosis	NOUN
dpc-826	20	21	-	-	PUNCT
dpc-826	20	22	directed	direct	VERB
dpc-826	20	23	treatment	treatment	NOUN
dpc-826	20	24	and	and	CCONJ
dpc-826	20	25	the	the	DET
dpc-826	20	26	patient	patient	NOUN
dpc-826	20	27	avoids	avoid	VERB
dpc-826	20	28	sun	sun	NOUN
dpc-826	20	29	exposure	exposure	NOUN
dpc-826	20	30	.	.	PUNCT
dpc-826	21	1	abstract	abstract	ADJ
dpc-826	21	2	122	122	NUM
dpc-826	21	3	observation	observation	NOUN
dpc-826	21	4	|	|	INTJ
dpc-826	21	5	dermatol	dermatol	NOUN
dpc-826	21	6	pract	pract	NOUN
dpc-826	21	7	concept	concept	NOUN
dpc-826	21	8	2015;5(2):24	2015;5(2):24	NUM
dpc-826	21	9	including	include	VERB
dpc-826	21	10	:	:	PUNCT
dpc-826	21	11	carboplatin	carboplatin	NOUN
dpc-826	21	12	and	and	CCONJ
dpc-826	21	13	pemetrexed	pemetrexed	NOUN
dpc-826	21	14	,	,	PUNCT
dpc-826	21	15	gemcitabine	gemcitabine	NOUN
dpc-826	21	16	,	,	PUNCT
dpc-826	21	17	and	and	CCONJ
dpc-826	21	18	vinorelbine	vinorelbine	NOUN
dpc-826	21	19	.	.	PUNCT
dpc-826	22	1	treatment	treatment	NOUN
dpc-826	22	2	with	with	ADP
dpc-826	22	3	nab	nab	NOUN
dpc-826	22	4	-	-	PUNCT
dpc-826	22	5	paclitaxel	paclitaxel	NOUN
dpc-826	22	6	[	[	PUNCT
dpc-826	22	7	185	185	NUM
dpc-826	22	8	milligrams	milligram	NOUN
dpc-826	22	9	(	(	PUNCT
dpc-826	22	10	100	100	NUM
dpc-826	22	11	mg	mg	PROPN
dpc-826	22	12	/	/	SYM
dpc-826	22	13	m2	m2	PROPN
dpc-826	22	14	)	)	PUNCT
dpc-826	22	15	each	each	DET
dpc-826	22	16	week	week	NOUN
dpc-826	22	17	]	]	PUNCT
dpc-826	22	18	had	have	AUX
dpc-826	22	19	been	be	AUX
dpc-826	22	20	initiated	initiate	VERB
dpc-826	22	21	two	two	NUM
dpc-826	22	22	months	month	NOUN
dpc-826	22	23	prior	prior	ADV
dpc-826	22	24	to	to	ADP
dpc-826	22	25	the	the	DET
dpc-826	22	26	development	development	NOUN
dpc-826	22	27	of	of	ADP
dpc-826	22	28	the	the	DET
dpc-826	22	29	rash	rash	NOUN
dpc-826	22	30	.	.	PUNCT
dpc-826	23	1	cutaneous	cutaneous	ADJ
dpc-826	23	2	examination	examination	NOUN
dpc-826	23	3	revealed	reveal	VERB
dpc-826	23	4	individual	individual	ADJ
dpc-826	23	5	and	and	CCONJ
dpc-826	23	6	confluent	confluent	ADJ
dpc-826	23	7	,	,	PUNCT
dpc-826	23	8	erythematous	erythematous	ADJ
dpc-826	23	9	and	and	CCONJ
dpc-826	23	10	scaly	scaly	NOUN
dpc-826	23	11	,	,	PUNCT
dpc-826	23	12	plaques	plaque	NOUN
dpc-826	23	13	on	on	ADP
dpc-826	23	14	the	the	DET
dpc-826	23	15	sun	sun	NOUN
dpc-826	23	16	-	-	PUNCT
dpc-826	23	17	exposed	expose	VERB
dpc-826	23	18	areas	area	NOUN
dpc-826	23	19	of	of	ADP
dpc-826	23	20	her	her	PRON
dpc-826	23	21	neck	neck	NOUN
dpc-826	23	22	and	and	CCONJ
dpc-826	23	23	arms	arm	NOUN
dpc-826	23	24	(	(	PUNCT
dpc-826	23	25	figure	figure	NOUN
dpc-826	23	26	1	1	NUM
dpc-826	23	27	)	)	PUNCT
dpc-826	23	28	.	.	PUNCT
dpc-826	24	1	hyperpigmentation	hyperpigmentation	NOUN
dpc-826	24	2	was	be	AUX
dpc-826	24	3	observed	observe	VERB
dpc-826	24	4	on	on	ADP
dpc-826	24	5	her	her	PRON
dpc-826	24	6	face	face	NOUN
dpc-826	24	7	,	,	PUNCT
dpc-826	24	8	neck	neck	NOUN
dpc-826	24	9	,	,	PUNCT
dpc-826	24	10	and	and	CCONJ
dpc-826	24	11	upper	upper	ADJ
dpc-826	24	12	chest	chest	NOUN
dpc-826	24	13	(	(	PUNCT
dpc-826	24	14	figures	figure	NOUN
dpc-826	24	15	1	1	NUM
dpc-826	24	16	and	and	CCONJ
dpc-826	24	17	2	2	NUM
dpc-826	24	18	)	)	PUNCT
dpc-826	24	19	.	.	PUNCT
dpc-826	25	1	punch	punch	VERB
dpc-826	25	2	biopsies	biopsy	NOUN
dpc-826	25	3	from	from	ADP
dpc-826	25	4	the	the	DET
dpc-826	25	5	extensor	extensor	NOUN
dpc-826	25	6	distal	distal	NOUN
dpc-826	25	7	left	leave	VERB
dpc-826	25	8	and	and	CCONJ
dpc-826	25	9	right	right	ADJ
dpc-826	25	10	arms	arm	NOUN
dpc-826	25	11	both	both	PRON
dpc-826	25	12	show	show	VERB
dpc-826	25	13	mild	mild	ADJ
dpc-826	25	14	spongiosis	spongiosis	NOUN
dpc-826	25	15	with	with	ADP
dpc-826	25	16	hyperkeratosis	hyperkeratosis	NOUN
dpc-826	25	17	;	;	PUNCT
dpc-826	25	18	scattered	scatter	VERB
dpc-826	25	19	dyskeratotic	dyskeratotic	ADJ
dpc-826	25	20	cells	cell	NOUN
dpc-826	25	21	are	be	AUX
dpc-826	25	22	present	present	ADJ
dpc-826	25	23	in	in	ADP
dpc-826	25	24	the	the	DET
dpc-826	25	25	epidermis	epidermis	NOUN
dpc-826	25	26	.	.	PUNCT
dpc-826	26	1	there	there	PRON
dpc-826	26	2	is	be	VERB
dpc-826	26	3	a	a	DET
dpc-826	26	4	sparse	sparse	ADJ
dpc-826	26	5	interface	interface	NOUN
dpc-826	26	6	dermatitis	dermatitis	NOUN
dpc-826	26	7	;	;	PUNCT
dpc-826	26	8	mild	mild	ADJ
dpc-826	26	9	incontinence	incontinence	NOUN
dpc-826	26	10	of	of	ADP
dpc-826	26	11	pigment	pigment	NOUN
dpc-826	26	12	is	be	AUX
dpc-826	26	13	present	present	ADJ
dpc-826	26	14	in	in	ADP
dpc-826	26	15	the	the	DET
dpc-826	26	16	dermis	dermis	NOUN
dpc-826	26	17	(	(	PUNCT
dpc-826	26	18	figure	figure	NOUN
dpc-826	26	19	3	3	NUM
dpc-826	26	20	)	)	PUNCT
dpc-826	26	21	.	.	PUNCT
dpc-826	27	1	colloidal	colloidal	NOUN
dpc-826	27	2	iron	iron	NOUN
dpc-826	27	3	stained	stain	VERB
dpc-826	27	4	sections	section	NOUN
dpc-826	27	5	demonstrate	demonstrate	VERB
dpc-826	27	6	a	a	DET
dpc-826	27	7	mild	mild	ADJ
dpc-826	27	8	increase	increase	NOUN
dpc-826	27	9	of	of	ADP
dpc-826	27	10	mucin	mucin	NOUN
dpc-826	27	11	(	(	PUNCT
dpc-826	27	12	figure	figure	NOUN
dpc-826	27	13	4	4	NUM
dpc-826	27	14	)	)	PUNCT
dpc-826	27	15	.	.	PUNCT
dpc-826	28	1	laboratory	laboratory	NOUN
dpc-826	28	2	studies	study	NOUN
dpc-826	28	3	revealed	reveal	VERB
dpc-826	28	4	a	a	DET
dpc-826	28	5	positive	positive	ADJ
dpc-826	28	6	ana	ana	NOUN
dpc-826	28	7	at	at	ADP
dpc-826	28	8	a	a	DET
dpc-826	28	9	low	low	ADJ
dpc-826	28	10	titer	titer	NOUN
dpc-826	28	11	of	of	ADP
dpc-826	28	12	1:160	1:160	NUM
dpc-826	28	13	with	with	ADP
dpc-826	28	14	a	a	DET
dpc-826	28	15	nucleolar	nucleolar	ADJ
dpc-826	28	16	pattern	pattern	NOUN
dpc-826	28	17	.	.	PUNCT
dpc-826	29	1	negative	negative	ADJ
dpc-826	29	2	studies	study	NOUN
dpc-826	29	3	included	include	VERB
dpc-826	29	4	antibody	antibody	NOUN
dpc-826	29	5	to	to	ADP
dpc-826	29	6	:	:	PUNCT
dpc-826	29	7	dsdna	dsdna	VERB
dpc-826	29	8	,	,	PUNCT
dpc-826	29	9	ro	ro	X
dpc-826	29	10	,	,	PUNCT
dpc-826	29	11	la	la	PROPN
dpc-826	29	12	,	,	PUNCT
dpc-826	29	13	smith	smith	PROPN
dpc-826	29	14	,	,	PUNCT
dpc-826	29	15	rnp	rnp	PROPN
dpc-826	29	16	,	,	PUNCT
dpc-826	29	17	scl-70	scl-70	PROPN
dpc-826	29	18	,	,	PUNCT
dpc-826	29	19	jo-1	jo-1	NUM
dpc-826	29	20	,	,	PUNCT
dpc-826	29	21	and	and	CCONJ
dpc-826	29	22	histone	histone	PROPN
dpc-826	29	23	igg	igg	PROPN
dpc-826	29	24	.	.	PUNCT
dpc-826	30	1	normal	normal	ADJ
dpc-826	30	2	studies	study	NOUN
dpc-826	30	3	included	include	VERB
dpc-826	30	4	:	:	PUNCT
dpc-826	30	5	creatine	creatine	PROPN
dpc-826	30	6	kinase	kinase	PROPN
dpc-826	30	7	,	,	PUNCT
dpc-826	30	8	aldolase	aldolase	NOUN
dpc-826	30	9	,	,	PUNCT
dpc-826	30	10	ldh	ldh	PROPN
dpc-826	30	11	,	,	PUNCT
dpc-826	30	12	ast	ast	NOUN
dpc-826	30	13	,	,	PUNCT
dpc-826	30	14	and	and	CCONJ
dpc-826	30	15	alt	alt	ADJ
dpc-826	30	16	.	.	PUNCT
dpc-826	31	1	after	after	ADP
dpc-826	31	2	correlating	correlate	VERB
dpc-826	31	3	the	the	DET
dpc-826	31	4	clinical	clinical	ADJ
dpc-826	31	5	,	,	PUNCT
dpc-826	31	6	pathology	pathology	NOUN
dpc-826	31	7	,	,	PUNCT
dpc-826	31	8	and	and	CCONJ
dpc-826	31	9	laboratory	laboratory	NOUN
dpc-826	31	10	findings	finding	NOUN
dpc-826	31	11	,	,	PUNCT
dpc-826	31	12	a	a	DET
dpc-826	31	13	diagnosis	diagnosis	NOUN
dpc-826	31	14	of	of	ADP
dpc-826	31	15	nab	nab	NOUN
dpc-826	31	16	-	-	PUNCT
dpc-826	31	17	paclitaxel	paclitaxel	NOUN
dpc-826	31	18	-	-	PUNCT
dpc-826	31	19	associated	associate	VERB
dpc-826	31	20	photosenintroduction	photosenintroduction	NOUN
dpc-826	31	21	taxane	taxane	NOUN
dpc-826	31	22	-	-	PUNCT
dpc-826	31	23	associated	associate	VERB
dpc-826	31	24	cutaneous	cutaneous	ADJ
dpc-826	31	25	adverse	adverse	ADJ
dpc-826	31	26	reactions	reaction	NOUN
dpc-826	31	27	include	include	VERB
dpc-826	31	28	photodermatoses	photodermatose	NOUN
dpc-826	31	29	[	[	X
dpc-826	31	30	1	1	NUM
dpc-826	31	31	-	-	SYM
dpc-826	31	32	3	3	NUM
dpc-826	31	33	]	]	PUNCT
dpc-826	31	34	.	.	PUNCT
dpc-826	32	1	we	we	PRON
dpc-826	32	2	describe	describe	VERB
dpc-826	32	3	a	a	DET
dpc-826	32	4	woman	woman	NOUN
dpc-826	32	5	with	with	ADP
dpc-826	32	6	non	non	ADJ
dpc-826	32	7	-	-	ADJ
dpc-826	32	8	small	small	ADJ
dpc-826	32	9	cell	cell	NOUN
dpc-826	32	10	lung	lung	NOUN
dpc-826	32	11	cancer	cancer	NOUN
dpc-826	32	12	who	who	PRON
dpc-826	32	13	developed	develop	VERB
dpc-826	32	14	a	a	DET
dpc-826	32	15	dermatitis	dermatitis	NOUN
dpc-826	32	16	on	on	ADP
dpc-826	32	17	sun	sun	NOUN
dpc-826	32	18	-	-	PUNCT
dpc-826	32	19	exposed	expose	VERB
dpc-826	32	20	areas	area	NOUN
dpc-826	32	21	that	that	PRON
dpc-826	32	22	progressively	progressively	ADV
dpc-826	32	23	worsened	worsen	VERB
dpc-826	32	24	with	with	ADP
dpc-826	32	25	each	each	DET
dpc-826	32	26	dose	dose	NOUN
dpc-826	32	27	of	of	ADP
dpc-826	32	28	nab	nab	NOUN
dpc-826	32	29	-	-	PUNCT
dpc-826	32	30	paclitaxel	paclitaxel	NOUN
dpc-826	32	31	.	.	PUNCT
dpc-826	33	1	we	we	PRON
dpc-826	33	2	also	also	ADV
dpc-826	33	3	review	review	VERB
dpc-826	33	4	other	other	ADJ
dpc-826	33	5	photodermatoses	photodermatose	NOUN
dpc-826	33	6	in	in	ADP
dpc-826	33	7	patients	patient	NOUN
dpc-826	33	8	receiving	receive	VERB
dpc-826	33	9	paclitaxel	paclitaxel	NOUN
dpc-826	33	10	or	or	CCONJ
dpc-826	33	11	nab	nab	NOUN
dpc-826	33	12	-	-	PUNCT
dpc-826	33	13	paclitaxel	paclitaxel	PROPN
dpc-826	33	14	and	and	CCONJ
dpc-826	33	15	address	address	VERB
dpc-826	33	16	the	the	DET
dpc-826	33	17	treatment	treatment	NOUN
dpc-826	33	18	options	option	NOUN
dpc-826	33	19	for	for	ADP
dpc-826	33	20	individuals	individual	NOUN
dpc-826	33	21	affected	affect	VERB
dpc-826	33	22	by	by	ADP
dpc-826	33	23	these	these	DET
dpc-826	33	24	drug	drug	NOUN
dpc-826	33	25	-	-	PUNCT
dpc-826	33	26	associated	associate	VERB
dpc-826	33	27	conditions	condition	NOUN
dpc-826	33	28	.	.	PUNCT
dpc-826	34	1	case	case	NOUN
dpc-826	34	2	report	report	VERB
dpc-826	34	3	a	a	DET
dpc-826	34	4	69	69	NUM
dpc-826	34	5	-	-	PUNCT
dpc-826	34	6	year	year	NOUN
dpc-826	34	7	-	-	PUNCT
dpc-826	34	8	old	old	ADJ
dpc-826	34	9	woman	woman	NOUN
dpc-826	34	10	presented	present	VERB
dpc-826	34	11	for	for	ADP
dpc-826	34	12	evaluation	evaluation	NOUN
dpc-826	34	13	with	with	ADP
dpc-826	34	14	a	a	DET
dpc-826	34	15	photodistributed	photodistribute	VERB
dpc-826	34	16	rash	rash	NOUN
dpc-826	34	17	on	on	ADP
dpc-826	34	18	the	the	DET
dpc-826	34	19	extensor	extensor	NOUN
dpc-826	34	20	surfaces	surface	NOUN
dpc-826	34	21	of	of	ADP
dpc-826	34	22	her	her	PRON
dpc-826	34	23	upper	upper	ADJ
dpc-826	34	24	extremities	extremity	NOUN
dpc-826	34	25	.	.	PUNCT
dpc-826	35	1	her	her	PRON
dpc-826	35	2	past	past	ADJ
dpc-826	35	3	medical	medical	ADJ
dpc-826	35	4	history	history	NOUN
dpc-826	35	5	was	be	AUX
dpc-826	35	6	significant	significant	ADJ
dpc-826	35	7	for	for	ADP
dpc-826	35	8	stage	stage	NOUN
dpc-826	35	9	iv	iv	NUM
dpc-826	35	10	non	non	ADJ
dpc-826	35	11	-	-	ADJ
dpc-826	35	12	small	small	ADJ
dpc-826	35	13	cell	cell	NOUN
dpc-826	35	14	lung	lung	NOUN
dpc-826	35	15	cancer	cancer	NOUN
dpc-826	35	16	.	.	PUNCT
dpc-826	36	1	she	she	PRON
dpc-826	36	2	had	have	VERB
dpc-826	36	3	progressive	progressive	ADJ
dpc-826	36	4	disease	disease	NOUN
dpc-826	36	5	after	after	ADP
dpc-826	36	6	sequentially	sequentially	ADV
dpc-826	36	7	receiving	receive	VERB
dpc-826	36	8	prior	prior	ADJ
dpc-826	36	9	antineoplastic	antineoplastic	ADJ
dpc-826	36	10	therapies	therapy	NOUN
dpc-826	36	11	,	,	PUNCT
dpc-826	36	12	figure	figure	NOUN
dpc-826	36	13	1	1	NUM
dpc-826	36	14	.	.	PUNCT
dpc-826	36	15	erythematous	erythematous	ADJ
dpc-826	36	16	plaques	plaque	NOUN
dpc-826	36	17	on	on	ADP
dpc-826	36	18	the	the	DET
dpc-826	36	19	sun	sun	NOUN
dpc-826	36	20	-	-	PUNCT
dpc-826	36	21	exposed	expose	VERB
dpc-826	36	22	extensor	extensor	NOUN
dpc-826	36	23	surfaces	surface	NOUN
dpc-826	36	24	of	of	ADP
dpc-826	36	25	the	the	DET
dpc-826	36	26	patient	patient	NOUN
dpc-826	36	27	’s	’s	PART
dpc-826	36	28	arms	arm	NOUN
dpc-826	36	29	with	with	ADP
dpc-826	36	30	focal	focal	ADJ
dpc-826	36	31	sparing	sparing	NOUN
dpc-826	36	32	of	of	ADP
dpc-826	36	33	the	the	DET
dpc-826	36	34	dermatosis	dermatosis	NOUN
dpc-826	36	35	on	on	ADP
dpc-826	36	36	her	her	PRON
dpc-826	36	37	left	left	ADJ
dpc-826	36	38	extensor	extensor	NOUN
dpc-826	36	39	arm	arm	NOUN
dpc-826	36	40	corresponding	correspond	VERB
dpc-826	36	41	to	to	ADP
dpc-826	36	42	the	the	DET
dpc-826	36	43	area	area	NOUN
dpc-826	36	44	of	of	ADP
dpc-826	36	45	her	her	PRON
dpc-826	36	46	skin	skin	NOUN
dpc-826	36	47	that	that	PRON
dpc-826	36	48	had	have	AUX
dpc-826	36	49	been	be	AUX
dpc-826	36	50	covered	cover	VERB
dpc-826	36	51	by	by	ADP
dpc-826	36	52	a	a	DET
dpc-826	36	53	wrist	wrist	NOUN
dpc-826	36	54	watch	watch	NOUN
dpc-826	36	55	;	;	PUNCT
dpc-826	36	56	there	there	PRON
dpc-826	36	57	is	be	VERB
dpc-826	36	58	also	also	ADV
dpc-826	36	59	hyperpigmentation	hyperpigmentation	NOUN
dpc-826	36	60	on	on	ADP
dpc-826	36	61	her	her	PRON
dpc-826	36	62	posterior	posterior	ADJ
dpc-826	36	63	neck	neck	NOUN
dpc-826	36	64	.	.	PUNCT
dpc-826	37	1	[	[	X
dpc-826	37	2	copyright	copyright	NOUN
dpc-826	37	3	:	:	PUNCT
dpc-826	37	4	©	©	PROPN
dpc-826	37	5	2015	2015	NUM
dpc-826	37	6	beutler	beutler	NOUN
dpc-826	37	7	et	et	PROPN
dpc-826	37	8	al	al	PROPN
dpc-826	37	9	.	.	PROPN
dpc-826	37	10	]	]	PUNCT
dpc-826	37	11	figure	figure	NOUN
dpc-826	37	12	2	2	NUM
dpc-826	37	13	.	.	PUNCT
dpc-826	37	14	hyperpigmentation	hyperpigmentation	NOUN
dpc-826	37	15	of	of	ADP
dpc-826	37	16	sun	sun	NOUN
dpc-826	37	17	-	-	PUNCT
dpc-826	37	18	exposed	expose	VERB
dpc-826	37	19	locations	location	NOUN
dpc-826	37	20	:	:	PUNCT
dpc-826	37	21	the	the	DET
dpc-826	37	22	face	face	NOUN
dpc-826	37	23	,	,	PUNCT
dpc-826	37	24	anterior	anterior	ADJ
dpc-826	37	25	neck	neck	NOUN
dpc-826	37	26	,	,	PUNCT
dpc-826	37	27	and	and	CCONJ
dpc-826	37	28	“	"	PUNCT
dpc-826	37	29	v	v	NOUN
dpc-826	37	30	”	"	PUNCT
dpc-826	37	31	area	area	NOUN
dpc-826	37	32	of	of	ADP
dpc-826	37	33	the	the	DET
dpc-826	37	34	upper	upper	ADJ
dpc-826	37	35	chest	chest	NOUN
dpc-826	37	36	.	.	PUNCT
dpc-826	38	1	[	[	X
dpc-826	38	2	copyright	copyright	NOUN
dpc-826	38	3	:	:	PUNCT
dpc-826	38	4	©	©	PROPN
dpc-826	38	5	2015	2015	NUM
dpc-826	38	6	beutler	beutler	NOUN
dpc-826	38	7	et	et	PROPN
dpc-826	38	8	al	al	PROPN
dpc-826	38	9	.	.	PROPN
dpc-826	38	10	]	]	PUNCT
dpc-826	38	11	figure	figure	NOUN
dpc-826	38	12	3	3	NUM
dpc-826	38	13	.	.	PUNCT
dpc-826	38	14	hematoxylin	hematoxylin	NOUN
dpc-826	38	15	and	and	CCONJ
dpc-826	38	16	eosin	eosin	NOUN
dpc-826	38	17	stained	stain	VERB
dpc-826	38	18	sections	section	NOUN
dpc-826	38	19	of	of	ADP
dpc-826	38	20	nab	nab	NOUN
dpc-826	38	21	-	-	PUNCT
dpc-826	38	22	paclitaxelassociated	paclitaxelassociate	VERB
dpc-826	38	23	photodermatitis	photodermatitis	PROPN
dpc-826	38	24	show	show	NOUN
dpc-826	38	25	hyperkeratosis	hyperkeratosis	NOUN
dpc-826	38	26	,	,	PUNCT
dpc-826	38	27	mild	mild	ADJ
dpc-826	38	28	acanthosis	acanthosis	NOUN
dpc-826	38	29	,	,	PUNCT
dpc-826	38	30	and	and	CCONJ
dpc-826	38	31	spongiosis	spongiosis	VERB
dpc-826	38	32	with	with	ADP
dpc-826	38	33	effacement	effacement	NOUN
dpc-826	38	34	of	of	ADP
dpc-826	38	35	the	the	DET
dpc-826	38	36	rete	rete	NOUN
dpc-826	38	37	ridges	ridge	NOUN
dpc-826	38	38	.	.	PUNCT
dpc-826	39	1	there	there	PRON
dpc-826	39	2	is	be	VERB
dpc-826	39	3	a	a	DET
dpc-826	39	4	sparse	sparse	ADJ
dpc-826	39	5	interface	interface	NOUN
dpc-826	39	6	dermatitis	dermatitis	NOUN
dpc-826	39	7	with	with	ADP
dpc-826	39	8	subtle	subtle	ADJ
dpc-826	39	9	alteration	alteration	NOUN
dpc-826	39	10	of	of	ADP
dpc-826	39	11	the	the	DET
dpc-826	39	12	epidermal	epidermal	ADJ
dpc-826	39	13	basal	basal	NOUN
dpc-826	39	14	layer	layer	NOUN
dpc-826	39	15	and	and	CCONJ
dpc-826	39	16	incontinence	incontinence	NOUN
dpc-826	39	17	of	of	ADP
dpc-826	39	18	pigment	pigment	NOUN
dpc-826	39	19	in	in	ADP
dpc-826	39	20	the	the	DET
dpc-826	39	21	papillary	papillary	ADJ
dpc-826	39	22	dermis	dermis	NOUN
dpc-826	39	23	(	(	PUNCT
dpc-826	39	24	hematoxylin	hematoxylin	NOUN
dpc-826	39	25	and	and	CCONJ
dpc-826	39	26	eosin	eosin	NOUN
dpc-826	39	27	;	;	PUNCT
dpc-826	39	28	x40	x40	NUM
dpc-826	39	29	)	)	PUNCT
dpc-826	39	30	.	.	PUNCT
dpc-826	40	1	[	[	X
dpc-826	40	2	copyright	copyright	NOUN
dpc-826	40	3	:	:	PUNCT
dpc-826	40	4	©	©	PROPN
dpc-826	40	5	2015	2015	NUM
dpc-826	40	6	beutler	beutler	NOUN
dpc-826	40	7	et	et	PROPN
dpc-826	40	8	al	al	PROPN
dpc-826	40	9	.	.	PROPN
dpc-826	40	10	]	]	PUNCT
dpc-826	40	11	figure	figure	NOUN
dpc-826	40	12	4	4	NUM
dpc-826	40	13	.	.	PUNCT
dpc-826	40	14	colloidal	colloidal	NOUN
dpc-826	40	15	iron	iron	NOUN
dpc-826	40	16	stained	stain	VERB
dpc-826	40	17	sections	section	NOUN
dpc-826	40	18	of	of	ADP
dpc-826	40	19	nab	nab	NOUN
dpc-826	40	20	-	-	PUNCT
dpc-826	40	21	paclitaxel	paclitaxel	NOUN
dpc-826	40	22	-	-	PUNCT
dpc-826	40	23	associated	associate	VERB
dpc-826	40	24	photodermatitis	photodermatitis	PROPN
dpc-826	40	25	show	show	VERB
dpc-826	40	26	a	a	DET
dpc-826	40	27	mild	mild	ADJ
dpc-826	40	28	increase	increase	NOUN
dpc-826	40	29	of	of	ADP
dpc-826	40	30	mucin	mucin	NOUN
dpc-826	40	31	in	in	ADP
dpc-826	40	32	the	the	DET
dpc-826	40	33	upper	upper	ADJ
dpc-826	40	34	dermis	dermis	NOUN
dpc-826	40	35	.	.	PUNCT
dpc-826	41	1	there	there	PRON
dpc-826	41	2	are	be	AUX
dpc-826	41	3	scattered	scatter	VERB
dpc-826	41	4	dyskeratotic	dyskeratotic	ADJ
dpc-826	41	5	cells	cell	NOUN
dpc-826	41	6	in	in	ADP
dpc-826	41	7	the	the	DET
dpc-826	41	8	epidermis	epidermis	NOUN
dpc-826	41	9	and	and	CCONJ
dpc-826	41	10	incontinence	incontinence	NOUN
dpc-826	41	11	of	of	ADP
dpc-826	41	12	pigment	pigment	NOUN
dpc-826	41	13	in	in	ADP
dpc-826	41	14	the	the	DET
dpc-826	41	15	papillary	papillary	ADJ
dpc-826	41	16	dermis	dermis	NOUN
dpc-826	41	17	(	(	PUNCT
dpc-826	41	18	colloidal	colloidal	NOUN
dpc-826	41	19	iron	iron	NOUN
dpc-826	41	20	;	;	PUNCT
dpc-826	41	21	x20	x20	NUM
dpc-826	41	22	)	)	PUNCT
dpc-826	41	23	.	.	PUNCT
dpc-826	42	1	[	[	X
dpc-826	42	2	copyright	copyright	NOUN
dpc-826	42	3	:	:	PUNCT
dpc-826	42	4	©	©	PROPN
dpc-826	42	5	2015	2015	NUM
dpc-826	42	6	beutler	beutler	NOUN
dpc-826	42	7	et	et	PROPN
dpc-826	42	8	al	al	PROPN
dpc-826	42	9	.	.	PROPN
dpc-826	42	10	]	]	PUNCT
dpc-826	43	1	observation	observation	NOUN
dpc-826	43	2	|	|	INTJ
dpc-826	43	3	dermatol	dermatol	NOUN
dpc-826	43	4	pract	pract	NOUN
dpc-826	43	5	concept	concept	NOUN
dpc-826	43	6	2015;5(2):24	2015;5(2):24	NUM
dpc-826	43	7	123	123	NUM
dpc-826	43	8	the	the	DET
dpc-826	43	9	face	face	NOUN
dpc-826	43	10	,	,	PUNCT
dpc-826	43	11	upper	upper	ADJ
dpc-826	43	12	central	central	ADJ
dpc-826	43	13	chest	chest	NOUN
dpc-826	43	14	,	,	PUNCT
dpc-826	43	15	and	and	CCONJ
dpc-826	43	16	extensor	extensor	NOUN
dpc-826	43	17	forearms	forearm	NOUN
dpc-826	43	18	.	.	PUNCT
dpc-826	44	1	the	the	DET
dpc-826	44	2	condition	condition	NOUN
dpc-826	44	3	was	be	AUX
dpc-826	44	4	successfully	successfully	ADV
dpc-826	44	5	treated	treat	VERB
dpc-826	44	6	with	with	ADP
dpc-826	44	7	topical	topical	ADJ
dpc-826	44	8	corticosteroids	corticosteroid	NOUN
dpc-826	44	9	and	and	CCONJ
dpc-826	44	10	strict	strict	ADJ
dpc-826	44	11	photoprotection	photoprotection	NOUN
dpc-826	44	12	.	.	PUNCT
dpc-826	45	1	the	the	DET
dpc-826	45	2	patient	patient	NOUN
dpc-826	45	3	was	be	AUX
dpc-826	45	4	able	able	ADJ
dpc-826	45	5	to	to	PART
dpc-826	45	6	continue	continue	VERB
dpc-826	45	7	to	to	PART
dpc-826	45	8	receive	receive	VERB
dpc-826	45	9	paclitaxel	paclitaxel	NOUN
dpc-826	45	10	therapy	therapy	NOUN
dpc-826	45	11	with	with	ADP
dpc-826	45	12	no	no	DET
dpc-826	45	13	recurrence	recurrence	NOUN
dpc-826	45	14	of	of	ADP
dpc-826	45	15	erythema	erythema	ADJ
dpc-826	45	16	multiforme	multiforme	NOUN
dpc-826	45	17	or	or	CCONJ
dpc-826	45	18	onycholysis	onycholysis	NOUN
dpc-826	46	1	[	[	X
dpc-826	46	2	1	1	NUM
dpc-826	46	3	]	]	PUNCT
dpc-826	46	4	.	.	PUNCT
dpc-826	47	1	photo	photo	NOUN
dpc-826	47	2	recall	recall	NOUN
dpc-826	47	3	phenomenon	phenomenon	NOUN
dpc-826	47	4	[	[	X
dpc-826	47	5	3	3	X
dpc-826	47	6	]	]	PUNCT
dpc-826	47	7	and	and	CCONJ
dpc-826	47	8	subacute	subacute	VERB
dpc-826	47	9	cutaneous	cutaneous	ADJ
dpc-826	47	10	lupus	lupus	PROPN
dpc-826	47	11	erythematosus	erythematosus	NOUN
dpc-826	48	1	[	[	X
dpc-826	48	2	8	8	NUM
dpc-826	48	3	-	-	SYM
dpc-826	48	4	10	10	NUM
dpc-826	48	5	]	]	PUNCT
dpc-826	48	6	have	have	AUX
dpc-826	48	7	been	be	AUX
dpc-826	48	8	associated	associate	VERB
dpc-826	48	9	with	with	ADP
dpc-826	48	10	paclitaxel	paclitaxel	ADJ
dpc-826	48	11	therapy	therapy	NOUN
dpc-826	48	12	in	in	ADP
dpc-826	48	13	female	female	ADJ
dpc-826	48	14	patients	patient	NOUN
dpc-826	48	15	.	.	PUNCT
dpc-826	49	1	one	one	NUM
dpc-826	49	2	woman	woman	NOUN
dpc-826	49	3	developed	develop	VERB
dpc-826	49	4	a	a	DET
dpc-826	49	5	lupus	lupus	ADJ
dpc-826	49	6	erythematosus	erythematosus	NOUN
dpc-826	49	7	-	-	PUNCT
dpc-826	49	8	like	like	ADJ
dpc-826	49	9	reaction	reaction	NOUN
dpc-826	49	10	one	one	NUM
dpc-826	49	11	day	day	NOUN
dpc-826	49	12	after	after	ADP
dpc-826	49	13	her	her	PRON
dpc-826	49	14	first	first	ADJ
dpc-826	49	15	dose	dose	NOUN
dpc-826	49	16	of	of	ADP
dpc-826	49	17	paclitaxel	paclitaxel	PROPN
dpc-826	49	18	.	.	PUNCT
dpc-826	50	1	she	she	PRON
dpc-826	50	2	presented	present	VERB
dpc-826	50	3	with	with	ADP
dpc-826	50	4	edema	edema	NOUN
dpc-826	50	5	and	and	CCONJ
dpc-826	50	6	erythema	erythema	ADV
dpc-826	50	7	spreading	spread	VERB
dpc-826	50	8	bilaterally	bilaterally	ADV
dpc-826	50	9	from	from	ADP
dpc-826	50	10	her	her	PRON
dpc-826	50	11	nose	nose	NOUN
dpc-826	50	12	to	to	ADP
dpc-826	50	13	her	her	PRON
dpc-826	50	14	cheeks	cheek	NOUN
dpc-826	50	15	.	.	PUNCT
dpc-826	51	1	a	a	DET
dpc-826	51	2	positive	positive	ADJ
dpc-826	51	3	ana	ana	NOUN
dpc-826	51	4	titer	titer	NOUN
dpc-826	51	5	of	of	ADP
dpc-826	51	6	1:40	1:40	NUM
dpc-826	51	7	in	in	ADP
dpc-826	51	8	a	a	DET
dpc-826	51	9	nucleolar	nucleolar	ADJ
dpc-826	51	10	pattern	pattern	NOUN
dpc-826	51	11	was	be	AUX
dpc-826	51	12	observed	observe	VERB
dpc-826	51	13	.	.	PUNCT
dpc-826	52	1	topical	topical	ADJ
dpc-826	52	2	and	and	CCONJ
dpc-826	52	3	systemic	systemic	ADJ
dpc-826	52	4	corticosteroids	corticosteroid	NOUN
dpc-826	52	5	were	be	AUX
dpc-826	52	6	administered	administer	VERB
dpc-826	52	7	and	and	CCONJ
dpc-826	52	8	the	the	DET
dpc-826	52	9	lesions	lesion	NOUN
dpc-826	52	10	began	begin	VERB
dpc-826	52	11	to	to	PART
dpc-826	52	12	clear	clear	VERB
dpc-826	52	13	.	.	PUNCT
dpc-826	53	1	interestingly	interestingly	ADV
dpc-826	53	2	,	,	PUNCT
dpc-826	53	3	the	the	DET
dpc-826	53	4	patient	patient	NOUN
dpc-826	53	5	was	be	AUX
dpc-826	53	6	subsequently	subsequently	ADV
dpc-826	53	7	able	able	ADJ
dpc-826	53	8	to	to	PART
dpc-826	53	9	tolerate	tolerate	VERB
dpc-826	53	10	nab	nab	VERB
dpc-826	53	11	-	-	PUNCT
dpc-826	53	12	paclitaxel	paclitaxel	ADJ
dpc-826	53	13	therapy	therapy	NOUN
dpc-826	53	14	;	;	PUNCT
dpc-826	53	15	the	the	DET
dpc-826	53	16	authors	author	NOUN
dpc-826	53	17	attributed	attribute	VERB
dpc-826	53	18	her	her	PRON
dpc-826	53	19	eruption	eruption	NOUN
dpc-826	53	20	to	to	ADP
dpc-826	53	21	the	the	DET
dpc-826	53	22	kolliphor	kolliphor	PROPN
dpc-826	53	23	el	el	PROPN
dpc-826	53	24	solvent	solvent	PROPN
dpc-826	53	25	rather	rather	ADV
dpc-826	53	26	than	than	ADP
dpc-826	53	27	the	the	DET
dpc-826	53	28	paclitaxel	paclitaxel	NOUN
dpc-826	53	29	[	[	X
dpc-826	53	30	10	10	NUM
dpc-826	53	31	]	]	PUNCT
dpc-826	53	32	.	.	PUNCT
dpc-826	54	1	however	however	ADV
dpc-826	54	2	,	,	PUNCT
dpc-826	54	3	a	a	DET
dpc-826	54	4	recent	recent	ADJ
dpc-826	54	5	report	report	NOUN
dpc-826	54	6	has	have	AUX
dpc-826	54	7	linked	link	VERB
dpc-826	54	8	subacute	subacute	ADJ
dpc-826	54	9	cutaneous	cutaneous	ADJ
dpc-826	54	10	lupus	lupus	PROPN
dpc-826	54	11	erythematosus	erythematosus	NOUN
dpc-826	54	12	to	to	PART
dpc-826	54	13	kolliphor	kolliphor	VERB
dpc-826	54	14	el	el	PROPN
dpc-826	54	15	-	-	PUNCT
dpc-826	54	16	free	free	ADJ
dpc-826	54	17	nab	nab	NOUN
dpc-826	54	18	-	-	PUNCT
dpc-826	54	19	paclitaxel	paclitaxel	NOUN
dpc-826	54	20	.	.	PUNCT
dpc-826	55	1	a	a	DET
dpc-826	55	2	62	62	NUM
dpc-826	55	3	-	-	PUNCT
dpc-826	55	4	year	year	NOUN
dpc-826	55	5	-	-	PUNCT
dpc-826	55	6	old	old	ADJ
dpc-826	55	7	woman	woman	NOUN
dpc-826	55	8	developed	develop	VERB
dpc-826	55	9	erythematous	erythematous	ADJ
dpc-826	55	10	papules	papule	NOUN
dpc-826	55	11	and	and	CCONJ
dpc-826	55	12	plaques	plaque	NOUN
dpc-826	55	13	of	of	ADP
dpc-826	55	14	subacute	subacute	ADJ
dpc-826	55	15	lupus	lupus	ADJ
dpc-826	55	16	erythematosus	erythematosus	NOUN
dpc-826	55	17	on	on	ADP
dpc-826	55	18	her	her	PRON
dpc-826	55	19	sun	sun	NOUN
dpc-826	55	20	-	-	PUNCT
dpc-826	55	21	exposed	expose	VERB
dpc-826	55	22	arms	arm	NOUN
dpc-826	55	23	and	and	CCONJ
dpc-826	55	24	chest	chest	NOUN
dpc-826	55	25	that	that	PRON
dpc-826	55	26	appeared	appear	VERB
dpc-826	55	27	after	after	ADP
dpc-826	55	28	her	her	PRON
dpc-826	55	29	third	third	ADJ
dpc-826	55	30	infusion	infusion	NOUN
dpc-826	55	31	with	with	ADP
dpc-826	55	32	nab	nab	NOUN
dpc-826	55	33	-	-	PUNCT
dpc-826	55	34	paclitaxel	paclitaxel	NOUN
dpc-826	55	35	.	.	PUNCT
dpc-826	56	1	the	the	DET
dpc-826	56	2	lesions	lesion	NOUN
dpc-826	56	3	completely	completely	ADV
dpc-826	56	4	disappeared	disappear	VERB
dpc-826	56	5	after	after	SCONJ
dpc-826	56	6	the	the	DET
dpc-826	56	7	nab	nab	NOUN
dpc-826	56	8	-	-	PUNCT
dpc-826	56	9	paclitaxel	paclitaxel	PROPN
dpc-826	56	10	was	be	AUX
dpc-826	56	11	withdrawn	withdraw	VERB
dpc-826	56	12	[	[	PUNCT
dpc-826	56	13	7	7	NUM
dpc-826	56	14	]	]	PUNCT
dpc-826	56	15	.	.	PUNCT
dpc-826	57	1	reports	report	NOUN
dpc-826	57	2	of	of	ADP
dpc-826	57	3	photosensitivity	photosensitivity	NOUN
dpc-826	57	4	dermatitis	dermatitis	NOUN
dpc-826	57	5	in	in	ADP
dpc-826	57	6	patients	patient	NOUN
dpc-826	57	7	receiving	receive	VERB
dpc-826	57	8	paclitaxel	paclitaxel	NOUN
dpc-826	57	9	or	or	CCONJ
dpc-826	57	10	nab	nab	NOUN
dpc-826	57	11	-	-	PUNCT
dpc-826	57	12	paclitaxel	paclitaxel	ADJ
dpc-826	57	13	therapy	therapy	NOUN
dpc-826	57	14	are	be	AUX
dpc-826	57	15	uncommon	uncommon	ADJ
dpc-826	57	16	.	.	PUNCT
dpc-826	58	1	however	however	ADV
dpc-826	58	2	,	,	PUNCT
dpc-826	58	3	it	it	PRON
dpc-826	58	4	is	be	AUX
dpc-826	58	5	possible	possible	ADJ
dpc-826	58	6	that	that	SCONJ
dpc-826	58	7	the	the	DET
dpc-826	58	8	incidence	incidence	NOUN
dpc-826	58	9	of	of	ADP
dpc-826	58	10	these	these	DET
dpc-826	58	11	cases	case	NOUN
dpc-826	58	12	is	be	AUX
dpc-826	58	13	higher	high	ADJ
dpc-826	58	14	than	than	SCONJ
dpc-826	58	15	reflected	reflect	VERB
dpc-826	58	16	in	in	ADP
dpc-826	58	17	the	the	DET
dpc-826	58	18	literature	literature	NOUN
dpc-826	58	19	.	.	PUNCT
dpc-826	59	1	we	we	PRON
dpc-826	59	2	hypothesize	hypothesize	VERB
dpc-826	59	3	that	that	SCONJ
dpc-826	59	4	additional	additional	ADJ
dpc-826	59	5	affected	affected	ADJ
dpc-826	59	6	individuals	individual	NOUN
dpc-826	59	7	may	may	AUX
dpc-826	59	8	not	not	PART
dpc-826	59	9	have	have	AUX
dpc-826	59	10	been	be	AUX
dpc-826	59	11	recognized	recognize	VERB
dpc-826	59	12	or	or	CCONJ
dpc-826	59	13	reported	report	VERB
dpc-826	59	14	since	since	SCONJ
dpc-826	59	15	the	the	DET
dpc-826	59	16	treatment	treatment	NOUN
dpc-826	59	17	duration	duration	NOUN
dpc-826	59	18	is	be	AUX
dpc-826	59	19	limited	limit	VERB
dpc-826	59	20	and	and	CCONJ
dpc-826	59	21	the	the	DET
dpc-826	59	22	dermatoses	dermatosis	NOUN
dpc-826	59	23	resolve	resolve	VERB
dpc-826	59	24	spontaneously	spontaneously	ADV
dpc-826	59	25	once	once	SCONJ
dpc-826	59	26	the	the	DET
dpc-826	59	27	agent	agent	NOUN
dpc-826	59	28	has	have	AUX
dpc-826	59	29	been	be	AUX
dpc-826	59	30	discontinued	discontinue	VERB
dpc-826	59	31	.	.	PUNCT
dpc-826	60	1	drug	drug	NOUN
dpc-826	60	2	-	-	PUNCT
dpc-826	60	3	induced	induce	VERB
dpc-826	60	4	photosensitivity	photosensitivity	NOUN
dpc-826	60	5	can	can	AUX
dpc-826	60	6	be	be	AUX
dpc-826	60	7	phototoxic	phototoxic	ADJ
dpc-826	60	8	or	or	CCONJ
dpc-826	60	9	photoallergic	photoallergic	NOUN
dpc-826	60	10	.	.	PUNCT
dpc-826	61	1	phototoxic	phototoxic	NOUN
dpc-826	61	2	dermatoses	dermatosis	NOUN
dpc-826	61	3	are	be	AUX
dpc-826	61	4	common	common	ADJ
dpc-826	61	5	and	and	CCONJ
dpc-826	61	6	typically	typically	ADV
dpc-826	61	7	present	present	ADJ
dpc-826	61	8	as	as	ADP
dpc-826	61	9	a	a	DET
dpc-826	61	10	sunburn	sunburn	NOUN
dpc-826	61	11	that	that	PRON
dpc-826	61	12	appears	appear	VERB
dpc-826	61	13	immediately	immediately	ADV
dpc-826	61	14	after	after	ADP
dpc-826	61	15	moderate	moderate	ADJ
dpc-826	61	16	exposure	exposure	NOUN
dpc-826	61	17	to	to	ADP
dpc-826	61	18	ultraviolet	ultraviolet	ADJ
dpc-826	61	19	radiation	radiation	NOUN
dpc-826	61	20	.	.	PUNCT
dpc-826	62	1	conversely	conversely	ADV
dpc-826	62	2	,	,	PUNCT
dpc-826	62	3	photoallergic	photoallergic	ADJ
dpc-826	62	4	reactions	reaction	NOUN
dpc-826	62	5	are	be	AUX
dpc-826	62	6	rare	rare	ADJ
dpc-826	62	7	and	and	CCONJ
dpc-826	62	8	are	be	AUX
dpc-826	62	9	often	often	ADV
dpc-826	62	10	characterized	characterize	VERB
dpc-826	62	11	by	by	ADP
dpc-826	62	12	pruritic	pruritic	ADJ
dpc-826	62	13	or	or	CCONJ
dpc-826	62	14	eczematous	eczematous	ADJ
dpc-826	62	15	lesions	lesion	NOUN
dpc-826	62	16	that	that	PRON
dpc-826	62	17	appear	appear	VERB
dpc-826	62	18	on	on	ADP
dpc-826	62	19	sun	sun	NOUN
dpc-826	62	20	exposed	expose	VERB
dpc-826	62	21	areas	area	NOUN
dpc-826	62	22	of	of	ADP
dpc-826	62	23	the	the	DET
dpc-826	62	24	skin	skin	NOUN
dpc-826	62	25	24	24	NUM
dpc-826	62	26	-	-	SYM
dpc-826	62	27	72	72	NUM
dpc-826	62	28	hours	hour	NOUN
dpc-826	62	29	after	after	ADP
dpc-826	62	30	minimal	minimal	ADJ
dpc-826	62	31	sun	sun	NOUN
dpc-826	62	32	exposure	exposure	NOUN
dpc-826	62	33	(	(	PUNCT
dpc-826	62	34	table	table	NOUN
dpc-826	62	35	1	1	NUM
dpc-826	62	36	)	)	PUNCT
dpc-826	63	1	[	[	X
dpc-826	63	2	11	11	NUM
dpc-826	63	3	]	]	PUNCT
dpc-826	63	4	.	.	PUNCT
dpc-826	64	1	the	the	DET
dpc-826	64	2	clinical	clinical	ADJ
dpc-826	64	3	presentation	presentation	NOUN
dpc-826	64	4	of	of	ADP
dpc-826	64	5	our	our	PRON
dpc-826	64	6	patient	patient	NOUN
dpc-826	64	7	’s	’s	PART
dpc-826	64	8	nab	nab	ADV
dpc-826	64	9	-	-	PUNCT
dpc-826	64	10	paclitaxelinduced	paclitaxelinduce	VERB
dpc-826	64	11	photodermatosis	photodermatosis	NOUN
dpc-826	64	12	is	be	AUX
dpc-826	64	13	most	most	ADV
dpc-826	64	14	consistent	consistent	ADJ
dpc-826	64	15	with	with	ADP
dpc-826	64	16	a	a	DET
dpc-826	64	17	photoallergic	photoallergic	ADJ
dpc-826	64	18	reaction	reaction	NOUN
dpc-826	64	19	.	.	PUNCT
dpc-826	65	1	the	the	DET
dpc-826	65	2	mechanism	mechanism	NOUN
dpc-826	65	3	of	of	ADP
dpc-826	65	4	pathogenesis	pathogenesis	NOUN
dpc-826	65	5	for	for	ADP
dpc-826	65	6	taxane	taxane	NOUN
dpc-826	65	7	-	-	PUNCT
dpc-826	65	8	associated	associate	VERB
dpc-826	65	9	photosensitivity	photosensitivity	NOUN
dpc-826	65	10	remains	remain	VERB
dpc-826	65	11	to	to	PART
dpc-826	65	12	be	be	AUX
dpc-826	65	13	determined	determine	VERB
dpc-826	65	14	.	.	PUNCT
dpc-826	66	1	in	in	ADP
dpc-826	66	2	some	some	PRON
dpc-826	66	3	of	of	ADP
dpc-826	66	4	the	the	DET
dpc-826	66	5	patients	patient	NOUN
dpc-826	66	6	treated	treat	VERB
dpc-826	66	7	with	with	ADP
dpc-826	66	8	paclitaxel	paclitaxel	NOUN
dpc-826	66	9	,	,	PUNCT
dpc-826	66	10	aberrations	aberration	NOUN
dpc-826	66	11	in	in	ADP
dpc-826	66	12	the	the	DET
dpc-826	66	13	biosynthesis	biosynthesis	NOUN
dpc-826	66	14	of	of	ADP
dpc-826	66	15	porphyrins	porphyrin	NOUN
dpc-826	66	16	have	have	AUX
dpc-826	66	17	been	be	AUX
dpc-826	66	18	demonstrated	demonstrate	VERB
dpc-826	66	19	[	[	PUNCT
dpc-826	66	20	10,12	10,12	NUM
dpc-826	66	21	]	]	PUNCT
dpc-826	66	22	.	.	PUNCT
dpc-826	67	1	whether	whether	SCONJ
dpc-826	67	2	elevated	elevated	ADJ
dpc-826	67	3	porphyrins	porphyrin	NOUN
dpc-826	67	4	are	be	AUX
dpc-826	67	5	an	an	DET
dpc-826	67	6	essential	essential	ADJ
dpc-826	67	7	feature	feature	NOUN
dpc-826	67	8	or	or	CCONJ
dpc-826	67	9	an	an	DET
dpc-826	67	10	epiphenomenon	epiphenomenon	NOUN
dpc-826	67	11	for	for	ADP
dpc-826	67	12	the	the	DET
dpc-826	67	13	development	development	NOUN
dpc-826	67	14	of	of	ADP
dpc-826	67	15	paclitaxel	paclitaxel	PROPN
dpc-826	67	16	-	-	PUNCT
dpc-826	67	17	related	relate	VERB
dpc-826	67	18	photosensitivity	photosensitivity	NOUN
dpc-826	67	19	remains	remain	VERB
dpc-826	67	20	to	to	PART
dpc-826	67	21	be	be	AUX
dpc-826	67	22	determined	determine	VERB
dpc-826	67	23	.	.	PUNCT
dpc-826	68	1	our	our	PRON
dpc-826	68	2	patient	patient	NOUN
dpc-826	68	3	declined	decline	VERB
dpc-826	68	4	additional	additional	ADJ
dpc-826	68	5	blood	blood	NOUN
dpc-826	68	6	and	and	CCONJ
dpc-826	68	7	urine	urine	NOUN
dpc-826	68	8	studies	study	NOUN
dpc-826	68	9	to	to	PART
dpc-826	68	10	evaluate	evaluate	VERB
dpc-826	68	11	porphyrins	porphyrin	NOUN
dpc-826	68	12	after	after	SCONJ
dpc-826	68	13	her	her	PRON
dpc-826	68	14	dermatosis	dermatosis	NOUN
dpc-826	68	15	resolved	resolve	VERB
dpc-826	68	16	.	.	PUNCT
dpc-826	69	1	sitive	sitive	ADJ
dpc-826	69	2	dermatitis	dermatitis	NOUN
dpc-826	69	3	was	be	AUX
dpc-826	69	4	established	establish	VERB
dpc-826	69	5	.	.	PUNCT
dpc-826	70	1	clobetasol	clobetasol	NOUN
dpc-826	70	2	0.05	0.05	NUM
dpc-826	70	3	%	%	NOUN
dpc-826	70	4	cream	cream	NOUN
dpc-826	70	5	was	be	AUX
dpc-826	70	6	applied	apply	VERB
dpc-826	70	7	twice	twice	ADV
dpc-826	70	8	daily	daily	ADV
dpc-826	70	9	and	and	CCONJ
dpc-826	70	10	she	she	PRON
dpc-826	70	11	avoided	avoid	VERB
dpc-826	70	12	exposure	exposure	NOUN
dpc-826	70	13	to	to	ADP
dpc-826	70	14	the	the	DET
dpc-826	70	15	sun	sun	NOUN
dpc-826	70	16	.	.	PUNCT
dpc-826	71	1	most	most	ADJ
dpc-826	71	2	of	of	ADP
dpc-826	71	3	the	the	DET
dpc-826	71	4	erythematous	erythematous	ADJ
dpc-826	71	5	plaques	plaque	NOUN
dpc-826	71	6	resolved	resolve	VERB
dpc-826	71	7	within	within	ADP
dpc-826	71	8	two	two	NUM
dpc-826	71	9	weeks	week	NOUN
dpc-826	71	10	.	.	PUNCT
dpc-826	72	1	triamcinolone	triamcinolone	NOUN
dpc-826	72	2	0.1	0.1	NUM
dpc-826	72	3	%	%	NOUN
dpc-826	72	4	cream	cream	NOUN
dpc-826	72	5	was	be	AUX
dpc-826	72	6	substituted	substitute	VERB
dpc-826	72	7	—	—	PUNCT
dpc-826	72	8	initially	initially	ADV
dpc-826	72	9	,	,	PUNCT
dpc-826	72	10	twice	twice	ADV
dpc-826	72	11	and	and	CCONJ
dpc-826	72	12	then	then	ADV
dpc-826	72	13	once	once	ADV
dpc-826	72	14	daily	daily	ADV
dpc-826	72	15	—	—	PUNCT
dpc-826	72	16	until	until	SCONJ
dpc-826	72	17	the	the	DET
dpc-826	72	18	dermatitis	dermatitis	NOUN
dpc-826	72	19	completely	completely	ADV
dpc-826	72	20	resolved	resolve	VERB
dpc-826	72	21	.	.	PUNCT
dpc-826	73	1	the	the	DET
dpc-826	73	2	patient	patient	NOUN
dpc-826	73	3	was	be	AUX
dpc-826	73	4	able	able	ADJ
dpc-826	73	5	to	to	PART
dpc-826	73	6	continue	continue	VERB
dpc-826	73	7	receiving	receive	VERB
dpc-826	73	8	nabpaclitaxel	nabpaclitaxel	NOUN
dpc-826	73	9	therapy	therapy	NOUN
dpc-826	73	10	without	without	ADP
dpc-826	73	11	recurrence	recurrence	NOUN
dpc-826	73	12	of	of	ADP
dpc-826	73	13	her	her	PRON
dpc-826	73	14	symptoms	symptom	NOUN
dpc-826	73	15	.	.	PUNCT
dpc-826	74	1	discussion	discussion	NOUN
dpc-826	74	2	taxanes	taxane	NOUN
dpc-826	74	3	are	be	AUX
dpc-826	74	4	used	use	VERB
dpc-826	74	5	in	in	ADP
dpc-826	74	6	the	the	DET
dpc-826	74	7	treatment	treatment	NOUN
dpc-826	74	8	of	of	ADP
dpc-826	74	9	lung	lung	NOUN
dpc-826	74	10	,	,	PUNCT
dpc-826	74	11	breast	breast	NOUN
dpc-826	74	12	,	,	PUNCT
dpc-826	74	13	ovarian	ovarian	ADJ
dpc-826	74	14	,	,	PUNCT
dpc-826	74	15	pancreatic	pancreatic	ADJ
dpc-826	74	16	,	,	PUNCT
dpc-826	74	17	and	and	CCONJ
dpc-826	74	18	head	head	NOUN
dpc-826	74	19	and	and	CCONJ
dpc-826	74	20	neck	neck	NOUN
dpc-826	74	21	cancers	cancer	NOUN
dpc-826	74	22	.	.	PUNCT
dpc-826	75	1	the	the	DET
dpc-826	75	2	first	first	ADJ
dpc-826	75	3	taxane	taxane	NOUN
dpc-826	75	4	,	,	PUNCT
dpc-826	75	5	paclitaxel	paclitaxel	PROPN
dpc-826	75	6	,	,	PUNCT
dpc-826	75	7	was	be	AUX
dpc-826	75	8	isolated	isolate	VERB
dpc-826	75	9	from	from	ADP
dpc-826	75	10	the	the	DET
dpc-826	75	11	bark	bark	NOUN
dpc-826	75	12	of	of	ADP
dpc-826	75	13	the	the	DET
dpc-826	75	14	pacific	pacific	PROPN
dpc-826	75	15	yew	yew	PROPN
dpc-826	75	16	tree	tree	NOUN
dpc-826	75	17	(	(	PUNCT
dpc-826	75	18	taxus	taxus	NOUN
dpc-826	75	19	brevifolin	brevifolin	NOUN
dpc-826	75	20	)	)	PUNCT
dpc-826	75	21	by	by	ADP
dpc-826	75	22	monroe	monroe	PROPN
dpc-826	75	23	e.	e.	PROPN
dpc-826	75	24	wall	wall	PROPN
dpc-826	75	25	and	and	CCONJ
dpc-826	75	26	mansukh	mansukh	PROPN
dpc-826	75	27	c.	c.	PROPN
dpc-826	75	28	wani	wani	PROPN
dpc-826	75	29	in	in	ADP
dpc-826	75	30	1967	1967	NUM
dpc-826	75	31	.	.	PUNCT
dpc-826	76	1	its	its	PRON
dpc-826	76	2	structure	structure	NOUN
dpc-826	76	3	was	be	AUX
dpc-826	76	4	subsequently	subsequently	ADV
dpc-826	76	5	elucidated	elucidate	VERB
dpc-826	76	6	in	in	ADP
dpc-826	76	7	1971	1971	NUM
dpc-826	76	8	.	.	PUNCT
dpc-826	77	1	however	however	ADV
dpc-826	77	2	,	,	PUNCT
dpc-826	77	3	due	due	ADP
dpc-826	77	4	to	to	ADP
dpc-826	77	5	the	the	DET
dpc-826	77	6	cost	cost	NOUN
dpc-826	77	7	and	and	CCONJ
dpc-826	77	8	difficulty	difficulty	NOUN
dpc-826	77	9	of	of	ADP
dpc-826	77	10	the	the	DET
dpc-826	77	11	extraction	extraction	NOUN
dpc-826	77	12	process	process	NOUN
dpc-826	77	13	and	and	CCONJ
dpc-826	77	14	the	the	DET
dpc-826	77	15	limited	limited	ADJ
dpc-826	77	16	supply	supply	NOUN
dpc-826	77	17	of	of	ADP
dpc-826	77	18	the	the	DET
dpc-826	77	19	pacific	pacific	PROPN
dpc-826	77	20	yew	yew	PROPN
dpc-826	77	21	tree	tree	NOUN
dpc-826	77	22	,	,	PUNCT
dpc-826	77	23	commercial	commercial	ADJ
dpc-826	77	24	development	development	NOUN
dpc-826	77	25	of	of	ADP
dpc-826	77	26	paclitaxel	paclitaxel	PROPN
dpc-826	77	27	did	do	AUX
dpc-826	77	28	not	not	PART
dpc-826	77	29	begin	begin	VERB
dpc-826	77	30	until	until	ADP
dpc-826	77	31	1991	1991	NUM
dpc-826	77	32	[	[	X
dpc-826	77	33	4,5	4,5	NUM
dpc-826	77	34	]	]	PUNCT
dpc-826	77	35	.	.	PUNCT
dpc-826	78	1	paclitaxel	paclitaxel	PROPN
dpc-826	78	2	is	be	AUX
dpc-826	78	3	poorly	poorly	ADV
dpc-826	78	4	soluble	soluble	ADJ
dpc-826	78	5	in	in	ADP
dpc-826	78	6	water	water	NOUN
dpc-826	78	7	and	and	CCONJ
dpc-826	78	8	thus	thus	ADV
dpc-826	78	9	most	most	ADV
dpc-826	78	10	commercially	commercially	ADV
dpc-826	78	11	available	available	ADJ
dpc-826	78	12	preparations	preparation	NOUN
dpc-826	78	13	once	once	ADV
dpc-826	78	14	contained	contain	VERB
dpc-826	78	15	the	the	DET
dpc-826	78	16	non	non	ADJ
dpc-826	78	17	-	-	ADJ
dpc-826	78	18	ionic	ionic	ADJ
dpc-826	78	19	solvent	solvent	NOUN
dpc-826	78	20	kolliphor	kolliphor	NOUN
dpc-826	78	21	el	el	PROPN
dpc-826	78	22	(	(	PUNCT
dpc-826	78	23	basf	basf	PROPN
dpc-826	78	24	,	,	PUNCT
dpc-826	78	25	usa	usa	PROPN
dpc-826	78	26	,	,	PUNCT
dpc-826	78	27	formerly	formerly	ADV
dpc-826	78	28	cremophor	cremophor	NOUN
dpc-826	78	29	el	el	PROPN
dpc-826	78	30	)	)	PUNCT
dpc-826	78	31	.	.	PUNCT
dpc-826	79	1	nanoparticle	nanoparticle	NOUN
dpc-826	79	2	albumin	albumin	NOUN
dpc-826	79	3	-	-	PUNCT
dpc-826	79	4	bound	bind	VERB
dpc-826	79	5	paclitaxel	paclitaxel	NOUN
dpc-826	79	6	(	(	PUNCT
dpc-826	79	7	nab	nab	NOUN
dpc-826	79	8	-	-	PUNCT
dpc-826	79	9	paclitaxel	paclitaxel	NOUN
dpc-826	79	10	)	)	PUNCT
dpc-826	79	11	was	be	AUX
dpc-826	79	12	developed	develop	VERB
dpc-826	79	13	in	in	ADP
dpc-826	79	14	order	order	NOUN
dpc-826	79	15	to	to	PART
dpc-826	79	16	reduce	reduce	VERB
dpc-826	79	17	or	or	CCONJ
dpc-826	79	18	eliminate	eliminate	VERB
dpc-826	79	19	the	the	DET
dpc-826	79	20	risk	risk	NOUN
dpc-826	79	21	of	of	ADP
dpc-826	79	22	hypersensitivity	hypersensitivity	NOUN
dpc-826	79	23	reactions	reaction	NOUN
dpc-826	79	24	associated	associate	VERB
dpc-826	79	25	with	with	ADP
dpc-826	79	26	kolliphor	kolliphor	PROPN
dpc-826	79	27	el	el	PROPN
dpc-826	79	28	-	-	PUNCT
dpc-826	79	29	based	base	VERB
dpc-826	79	30	paclitaxel	paclitaxel	PROPN
dpc-826	79	31	.	.	PUNCT
dpc-826	80	1	nab	nab	NOUN
dpc-826	80	2	-	-	PUNCT
dpc-826	80	3	paclitaxel	paclitaxel	NOUN
dpc-826	80	4	,	,	PUNCT
dpc-826	80	5	marketed	market	VERB
dpc-826	80	6	under	under	ADP
dpc-826	80	7	the	the	DET
dpc-826	80	8	trade	trade	NOUN
dpc-826	80	9	name	name	NOUN
dpc-826	80	10	“	"	PUNCT
dpc-826	80	11	abraxane	abraxane	ADJ
dpc-826	80	12	,	,	PUNCT
dpc-826	80	13	”	"	PUNCT
dpc-826	80	14	is	be	AUX
dpc-826	80	15	an	an	DET
dpc-826	80	16	injectable	injectable	ADJ
dpc-826	80	17	formulation	formulation	NOUN
dpc-826	80	18	of	of	ADP
dpc-826	80	19	albumin	albumin	NOUN
dpc-826	80	20	-	-	PUNCT
dpc-826	80	21	linked	link	VERB
dpc-826	80	22	paclitaxel	paclitaxel	NOUN
dpc-826	80	23	that	that	PRON
dpc-826	80	24	can	can	AUX
dpc-826	80	25	be	be	AUX
dpc-826	80	26	administered	administer	VERB
dpc-826	80	27	without	without	ADP
dpc-826	80	28	steroid	steroid	NOUN
dpc-826	80	29	or	or	CCONJ
dpc-826	80	30	antihistamine	antihistamine	NOUN
dpc-826	80	31	prophylaxis	prophylaxis	NOUN
dpc-826	80	32	for	for	ADP
dpc-826	80	33	hypersensitivity	hypersensitivity	NOUN
dpc-826	80	34	reactions	reaction	NOUN
dpc-826	80	35	[	[	X
dpc-826	80	36	6	6	NUM
dpc-826	80	37	]	]	PUNCT
dpc-826	80	38	.	.	PUNCT
dpc-826	81	1	paclitaxel	paclitaxel	PROPN
dpc-826	81	2	-	-	PUNCT
dpc-826	81	3	induced	induce	VERB
dpc-826	81	4	photodermatoses	photodermatose	NOUN
dpc-826	81	5	include	include	VERB
dpc-826	81	6	erythema	erythema	ADJ
dpc-826	81	7	multiforme	multiforme	NOUN
dpc-826	81	8	,	,	PUNCT
dpc-826	81	9	onycholysis	onycholysis	NOUN
dpc-826	81	10	,	,	PUNCT
dpc-826	81	11	photo	photo	NOUN
dpc-826	81	12	recall	recall	NOUN
dpc-826	81	13	phenomenon	phenomenon	NOUN
dpc-826	81	14	,	,	PUNCT
dpc-826	81	15	and	and	CCONJ
dpc-826	81	16	subacute	subacute	VERB
dpc-826	81	17	cutaneous	cutaneous	ADJ
dpc-826	81	18	lupus	lupus	PROPN
dpc-826	81	19	erythematosus	erythematosus	NOUN
dpc-826	82	1	[	[	X
dpc-826	82	2	1	1	NUM
dpc-826	82	3	]	]	PUNCT
dpc-826	82	4	.	.	PUNCT
dpc-826	83	1	it	it	PRON
dpc-826	83	2	is	be	AUX
dpc-826	83	3	possible	possible	ADJ
dpc-826	83	4	that	that	SCONJ
dpc-826	83	5	the	the	DET
dpc-826	83	6	photodermatosis	photodermatosis	NOUN
dpc-826	83	7	in	in	ADP
dpc-826	83	8	some	some	PRON
dpc-826	83	9	of	of	ADP
dpc-826	83	10	these	these	DET
dpc-826	83	11	patients	patient	NOUN
dpc-826	83	12	was	be	AUX
dpc-826	83	13	associated	associate	VERB
dpc-826	83	14	with	with	ADP
dpc-826	83	15	kolliphor	kolliphor	PROPN
dpc-826	83	16	el	el	PROPN
dpc-826	83	17	rather	rather	ADV
dpc-826	83	18	than	than	ADP
dpc-826	83	19	paclitaxel	paclitaxel	PROPN
dpc-826	83	20	.	.	PUNCT
dpc-826	84	1	to	to	ADP
dpc-826	84	2	the	the	DET
dpc-826	84	3	best	good	ADJ
dpc-826	84	4	of	of	ADP
dpc-826	84	5	our	our	PRON
dpc-826	84	6	knowledge	knowledge	NOUN
dpc-826	84	7	,	,	PUNCT
dpc-826	84	8	subacute	subacute	VERB
dpc-826	84	9	cutaneous	cutaneous	ADJ
dpc-826	84	10	lupus	lupus	PROPN
dpc-826	84	11	erythematosus	erythematosus	NOUN
dpc-826	84	12	is	be	AUX
dpc-826	84	13	the	the	DET
dpc-826	84	14	only	only	ADJ
dpc-826	84	15	photosensitivity	photosensitivity	NOUN
dpc-826	84	16	disorder	disorder	NOUN
dpc-826	84	17	that	that	PRON
dpc-826	84	18	has	have	AUX
dpc-826	84	19	been	be	AUX
dpc-826	84	20	linked	link	VERB
dpc-826	84	21	specifically	specifically	ADV
dpc-826	84	22	to	to	ADP
dpc-826	84	23	nab	nab	VERB
dpc-826	84	24	-	-	PUNCT
dpc-826	84	25	paclitaxel	paclitaxel	ADJ
dpc-826	84	26	therapy	therapy	NOUN
dpc-826	85	1	[	[	X
dpc-826	85	2	7	7	NUM
dpc-826	85	3	]	]	PUNCT
dpc-826	85	4	.	.	PUNCT
dpc-826	86	1	paclitaxel	paclitaxel	PROPN
dpc-826	86	2	-	-	PUNCT
dpc-826	86	3	induced	induce	VERB
dpc-826	86	4	erythema	erythema	ADJ
dpc-826	86	5	multiforme	multiforme	NOUN
dpc-826	86	6	on	on	ADP
dpc-826	86	7	sun	sun	NOUN
dpc-826	86	8	-	-	PUNCT
dpc-826	86	9	exposed	expose	VERB
dpc-826	86	10	skin	skin	NOUN
dpc-826	86	11	has	have	AUX
dpc-826	86	12	previously	previously	ADV
dpc-826	86	13	been	be	AUX
dpc-826	86	14	observed	observe	VERB
dpc-826	86	15	.	.	PUNCT
dpc-826	87	1	a	a	DET
dpc-826	87	2	40	40	NUM
dpc-826	87	3	-	-	PUNCT
dpc-826	87	4	year	year	NOUN
dpc-826	87	5	-	-	PUNCT
dpc-826	87	6	old	old	ADJ
dpc-826	87	7	woman	woman	NOUN
dpc-826	87	8	with	with	ADP
dpc-826	87	9	metastatic	metastatic	ADJ
dpc-826	87	10	breast	breast	NOUN
dpc-826	87	11	cancer	cancer	NOUN
dpc-826	87	12	presented	present	VERB
dpc-826	87	13	with	with	ADP
dpc-826	87	14	photodistributed	photodistribute	VERB
dpc-826	87	15	erythema	erythema	ADJ
dpc-826	87	16	multiforme	multiforme	NOUN
dpc-826	87	17	and	and	CCONJ
dpc-826	87	18	onycholysis	onycholysis	NOUN
dpc-826	87	19	following	follow	VERB
dpc-826	87	20	treatment	treatment	NOUN
dpc-826	87	21	with	with	ADP
dpc-826	87	22	paclitaxel	paclitaxel	NOUN
dpc-826	87	23	and	and	CCONJ
dpc-826	87	24	trastuzumab	trastuzumab	NOUN
dpc-826	87	25	.	.	PUNCT
dpc-826	88	1	elevated	elevated	ADJ
dpc-826	88	2	urinary	urinary	ADJ
dpc-826	88	3	and	and	CCONJ
dpc-826	88	4	erythrocyte	erythrocyte	NOUN
dpc-826	88	5	porphyrins	porphyrin	NOUN
dpc-826	88	6	were	be	AUX
dpc-826	88	7	also	also	ADV
dpc-826	88	8	observed	observe	VERB
dpc-826	88	9	.	.	PUNCT
dpc-826	89	1	the	the	DET
dpc-826	89	2	severity	severity	NOUN
dpc-826	89	3	of	of	ADP
dpc-826	89	4	the	the	DET
dpc-826	89	5	reaction	reaction	NOUN
dpc-826	89	6	necessitated	necessitate	VERB
dpc-826	89	7	withdrawal	withdrawal	NOUN
dpc-826	89	8	of	of	ADP
dpc-826	89	9	paclitaxel	paclitaxel	PROPN
dpc-826	89	10	therapy	therapy	NOUN
dpc-826	89	11	.	.	PUNCT
dpc-826	90	1	the	the	DET
dpc-826	90	2	lesions	lesion	NOUN
dpc-826	90	3	gradually	gradually	ADV
dpc-826	90	4	resolved	resolve	VERB
dpc-826	90	5	and	and	CCONJ
dpc-826	90	6	the	the	DET
dpc-826	90	7	porphyrins	porphyrin	NOUN
dpc-826	90	8	normalized	normalize	VERB
dpc-826	90	9	following	follow	VERB
dpc-826	90	10	withdrawal	withdrawal	NOUN
dpc-826	90	11	of	of	ADP
dpc-826	90	12	the	the	DET
dpc-826	90	13	drug	drug	NOUN
dpc-826	90	14	[	[	X
dpc-826	90	15	2	2	NUM
dpc-826	90	16	]	]	PUNCT
dpc-826	90	17	.	.	PUNCT
dpc-826	91	1	another	another	DET
dpc-826	91	2	patient	patient	NOUN
dpc-826	91	3	—	—	PUNCT
dpc-826	91	4	a	a	DET
dpc-826	91	5	56	56	NUM
dpc-826	91	6	-	-	PUNCT
dpc-826	91	7	year	year	NOUN
dpc-826	91	8	-	-	PUNCT
dpc-826	91	9	old	old	ADJ
dpc-826	91	10	woman	woman	NOUN
dpc-826	91	11	who	who	PRON
dpc-826	91	12	was	be	AUX
dpc-826	91	13	receiving	receive	VERB
dpc-826	91	14	adjuvant	adjuvant	ADJ
dpc-826	91	15	weekly	weekly	ADJ
dpc-826	91	16	paclitaxel	paclitaxel	NOUN
dpc-826	91	17	for	for	ADP
dpc-826	91	18	the	the	DET
dpc-826	91	19	treatment	treatment	NOUN
dpc-826	91	20	of	of	ADP
dpc-826	91	21	intraductal	intraductal	ADJ
dpc-826	91	22	breast	breast	NOUN
dpc-826	91	23	carcinoma	carcinoma	NOUN
dpc-826	91	24	—	—	PUNCT
dpc-826	91	25	developed	develop	VERB
dpc-826	91	26	photodistributed	photodistribute	VERB
dpc-826	91	27	erythema	erythema	ADJ
dpc-826	91	28	multiforme	multiforme	NOUN
dpc-826	91	29	and	and	CCONJ
dpc-826	91	30	onycholysis	onycholysis	NOUN
dpc-826	91	31	shortly	shortly	ADV
dpc-826	91	32	after	after	ADP
dpc-826	91	33	brief	brief	ADJ
dpc-826	91	34	exposure	exposure	NOUN
dpc-826	91	35	to	to	ADP
dpc-826	91	36	sunlight	sunlight	NOUN
dpc-826	91	37	.	.	PUNCT
dpc-826	92	1	she	she	PRON
dpc-826	92	2	developed	develop	VERB
dpc-826	92	3	pruritic	pruritic	ADJ
dpc-826	92	4	and	and	CCONJ
dpc-826	92	5	erythematous	erythematous	ADJ
dpc-826	92	6	skin	skin	NOUN
dpc-826	92	7	lesions	lesion	NOUN
dpc-826	92	8	that	that	PRON
dpc-826	92	9	spread	spread	VERB
dpc-826	92	10	only	only	ADV
dpc-826	92	11	to	to	ADP
dpc-826	92	12	sites	site	NOUN
dpc-826	92	13	that	that	PRON
dpc-826	92	14	were	be	AUX
dpc-826	92	15	exposed	expose	VERB
dpc-826	92	16	to	to	ADP
dpc-826	92	17	sunlight	sunlight	NOUN
dpc-826	92	18	:	:	PUNCT
dpc-826	92	19	124	124	NUM
dpc-826	92	20	observation	observation	NOUN
dpc-826	92	21	|	|	INTJ
dpc-826	92	22	dermatol	dermatol	NOUN
dpc-826	92	23	pract	pract	NOUN
dpc-826	92	24	concept	concept	NOUN
dpc-826	92	25	2015;5(2):24	2015;5(2):24	NUM
dpc-826	92	26	related	related	ADJ
dpc-826	92	27	,	,	PUNCT
dpc-826	92	28	photosensitive	photosensitive	ADJ
dpc-826	92	29	conditions	condition	NOUN
dpc-826	92	30	in	in	ADP
dpc-826	92	31	patients	patient	NOUN
dpc-826	92	32	with	with	ADP
dpc-826	92	33	cancer	cancer	NOUN
dpc-826	92	34	.	.	PUNCT
dpc-826	93	1	j	j	PROPN
dpc-826	93	2	drugs	drug	NOUN
dpc-826	93	3	dermatol	dermatol	VERB
dpc-826	93	4	2009;8(1):61	2009;8(1):61	NUM
dpc-826	93	5	-	-	SYM
dpc-826	93	6	64	64	NUM
dpc-826	93	7	.	.	PUNCT
dpc-826	94	1	pmid	pmid	NOUN
dpc-826	94	2	:	:	PUNCT
dpc-826	94	3	19180897	19180897	NUM
dpc-826	94	4	.	.	PUNCT
dpc-826	95	1	2	2	X
dpc-826	95	2	.	.	X
dpc-826	95	3	cohen	cohen	NOUN
dpc-826	95	4	ad	ad	NOUN
dpc-826	95	5	,	,	PUNCT
dpc-826	95	6	mermershtain	mermershtain	PROPN
dpc-826	95	7	w	w	PROPN
dpc-826	95	8	,	,	PUNCT
dpc-826	95	9	geffen	geffen	PROPN
dpc-826	95	10	db	db	PROPN
dpc-826	95	11	,	,	PUNCT
dpc-826	95	12	et	et	PROPN
dpc-826	95	13	al	al	PROPN
dpc-826	95	14	.	.	PUNCT
dpc-826	96	1	cutaneous	cutaneous	ADJ
dpc-826	96	2	photosensitivity	photosensitivity	NOUN
dpc-826	96	3	induced	induce	VERB
dpc-826	96	4	by	by	ADP
dpc-826	96	5	paclitaxel	paclitaxel	NOUN
dpc-826	96	6	and	and	CCONJ
dpc-826	96	7	trastuzumab	trastuzumab	NOUN
dpc-826	96	8	therapy	therapy	NOUN
dpc-826	96	9	associated	associate	VERB
dpc-826	96	10	with	with	ADP
dpc-826	96	11	aberrations	aberration	NOUN
dpc-826	96	12	in	in	ADP
dpc-826	96	13	the	the	DET
dpc-826	96	14	biosynthesis	biosynthesis	NOUN
dpc-826	96	15	of	of	ADP
dpc-826	96	16	porphyrins	porphyrin	NOUN
dpc-826	96	17	.	.	PUNCT
dpc-826	97	1	j	j	PROPN
dpc-826	97	2	dermatolog	dermatolog	PROPN
dpc-826	97	3	treat	treat	VERB
dpc-826	97	4	2005;16(1):19	2005;16(1):19	NUM
dpc-826	97	5	-	-	SYM
dpc-826	97	6	21	21	NUM
dpc-826	97	7	.	.	PUNCT
dpc-826	98	1	pmid	pmid	NOUN
dpc-826	98	2	:	:	PUNCT
dpc-826	98	3	15897162	15897162	NUM
dpc-826	98	4	.	.	PUNCT
dpc-826	99	1	3	3	X
dpc-826	99	2	.	.	X
dpc-826	99	3	ee	ee	PROPN
dpc-826	99	4	hl	hl	PROPN
dpc-826	99	5	,	,	PUNCT
dpc-826	99	6	yosipovitch	yosipovitch	PROPN
dpc-826	99	7	g.	g.	PROPN
dpc-826	99	8	photo	photo	PROPN
dpc-826	99	9	recall	recall	PROPN
dpc-826	99	10	phenomenon	phenomenon	NOUN
dpc-826	99	11	:	:	PUNCT
dpc-826	99	12	an	an	DET
dpc-826	99	13	adverse	adverse	ADJ
dpc-826	99	14	reaction	reaction	NOUN
dpc-826	99	15	to	to	ADP
dpc-826	99	16	taxanes	taxane	NOUN
dpc-826	99	17	.	.	PUNCT
dpc-826	100	1	dermatology	dermatology	NOUN
dpc-826	100	2	2003;207(2):196	2003;207(2):196	PROPN
dpc-826	100	3	-	-	SYM
dpc-826	100	4	198	198	NUM
dpc-826	100	5	.	.	PUNCT
dpc-826	101	1	pmid	pmid	NOUN
dpc-826	101	2	:	:	PUNCT
dpc-826	101	3	12920374	12920374	NUM
dpc-826	101	4	.	.	PUNCT
dpc-826	102	1	4	4	X
dpc-826	102	2	.	.	X
dpc-826	102	3	pazdur	pazdur	PROPN
dpc-826	102	4	r	r	NOUN
dpc-826	102	5	,	,	PUNCT
dpc-826	102	6	kudelka	kudelka	NOUN
dpc-826	102	7	ap	ap	PROPN
dpc-826	102	8	,	,	PUNCT
dpc-826	102	9	kavanagh	kavanagh	PROPN
dpc-826	102	10	jj	jj	PROPN
dpc-826	102	11	,	,	PUNCT
dpc-826	102	12	cohen	cohen	PROPN
dpc-826	102	13	pr	pr	PROPN
dpc-826	102	14	,	,	PUNCT
dpc-826	102	15	raber	raber	PROPN
dpc-826	102	16	mn	mn	PROPN
dpc-826	102	17	.	.	PUNCT
dpc-826	103	1	the	the	DET
dpc-826	103	2	taxoids	taxoids	PROPN
dpc-826	103	3	:	:	PUNCT
dpc-826	103	4	paclitaxel	paclitaxel	PROPN
dpc-826	103	5	(	(	PUNCT
dpc-826	103	6	taxol	taxol	PROPN
dpc-826	103	7	)	)	PUNCT
dpc-826	103	8	and	and	CCONJ
dpc-826	103	9	docetaxel	docetaxel	PROPN
dpc-826	103	10	(	(	PUNCT
dpc-826	103	11	taxotere	taxotere	PROPN
dpc-826	103	12	)	)	PUNCT
dpc-826	103	13	.	.	PUNCT
dpc-826	104	1	cancer	cancer	NOUN
dpc-826	104	2	treat	treat	NOUN
dpc-826	104	3	rev	rev	VERB
dpc-826	104	4	1993;19(4):351	1993;19(4):351	PROPN
dpc-826	104	5	-	-	PUNCT
dpc-826	104	6	386	386	NUM
dpc-826	104	7	.	.	PUNCT
dpc-826	105	1	pmid	pmid	NOUN
dpc-826	105	2	:	:	PUNCT
dpc-826	105	3	8106152	8106152	NUM
dpc-826	105	4	.	.	PUNCT
dpc-826	106	1	5	5	X
dpc-826	106	2	.	.	X
dpc-826	106	3	wall	wall	VERB
dpc-826	106	4	me	i	PRON
dpc-826	106	5	,	,	PUNCT
dpc-826	106	6	wani	wani	PROPN
dpc-826	106	7	mc	mc	PROPN
dpc-826	106	8	.	.	PROPN
dpc-826	106	9	camptothecin	camptothecin	PROPN
dpc-826	106	10	and	and	CCONJ
dpc-826	106	11	taxol	taxol	PROPN
dpc-826	106	12	:	:	PUNCT
dpc-826	106	13	discovery	discovery	NOUN
dpc-826	106	14	to	to	ADP
dpc-826	106	15	clinic	clinic	NOUN
dpc-826	106	16	—	—	PUNCT
dpc-826	106	17	thirteenth	thirteenth	PROPN
dpc-826	106	18	bruce	bruce	PROPN
dpc-826	106	19	f.	f.	PROPN
dpc-826	106	20	cain	cain	PROPN
dpc-826	106	21	memorial	memorial	PROPN
dpc-826	106	22	award	award	PROPN
dpc-826	106	23	lecture	lecture	NOUN
dpc-826	106	24	.	.	PUNCT
dpc-826	107	1	cancer	cancer	NOUN
dpc-826	107	2	res	re	NOUN
dpc-826	107	3	1995;55(4):753	1995;55(4):753	NUM
dpc-826	107	4	-	-	SYM
dpc-826	107	5	760	760	NUM
dpc-826	107	6	.	.	PUNCT
dpc-826	108	1	pmid	pmid	NOUN
dpc-826	108	2	:	:	PUNCT
dpc-826	108	3	7850785	7850785	NUM
dpc-826	108	4	.	.	PUNCT
dpc-826	109	1	6	6	NUM
dpc-826	109	2	.	.	X
dpc-826	109	3	yardley	yardley	PROPN
dpc-826	109	4	da	da	PROPN
dpc-826	109	5	.	.	PUNCT
dpc-826	110	1	nab	nab	PROPN
dpc-826	110	2	-	-	PUNCT
dpc-826	110	3	paclitaxel	paclitaxel	ADJ
dpc-826	110	4	mechanisms	mechanism	NOUN
dpc-826	110	5	of	of	ADP
dpc-826	110	6	action	action	NOUN
dpc-826	110	7	and	and	CCONJ
dpc-826	110	8	delivery	delivery	NOUN
dpc-826	110	9	.	.	PUNCT
dpc-826	111	1	j	j	PROPN
dpc-826	111	2	control	control	PROPN
dpc-826	111	3	release	release	PROPN
dpc-826	111	4	.	.	PUNCT
dpc-826	112	1	2013;170(3):365	2013;170(3):365	NUM
dpc-826	112	2	-	-	SYM
dpc-826	112	3	372	372	NUM
dpc-826	112	4	.	.	PUNCT
dpc-826	113	1	pmid	pmid	NOUN
dpc-826	113	2	:	:	PUNCT
dpc-826	113	3	23770008	23770008	NUM
dpc-826	113	4	.	.	PUNCT
dpc-826	114	1	7	7	X
dpc-826	114	2	.	.	X
dpc-826	114	3	lamond	lamond	PROPN
dpc-826	114	4	nw	nw	PROPN
dpc-826	114	5	,	,	PUNCT
dpc-826	114	6	younis	younis	PROPN
dpc-826	114	7	t	t	PROPN
dpc-826	114	8	,	,	PUNCT
dpc-826	114	9	purdy	purdy	PROPN
dpc-826	114	10	k	k	PROPN
dpc-826	114	11	,	,	PUNCT
dpc-826	114	12	dorreen	dorreen	PROPN
dpc-826	114	13	ms	ms	PROPN
dpc-826	114	14	.	.	PROPN
dpc-826	114	15	drug	drug	NOUN
dpc-826	114	16	-	-	PUNCT
dpc-826	114	17	induced	induce	VERB
dpc-826	114	18	subacute	subacute	NOUN
dpc-826	114	19	cutaneous	cutaneous	ADJ
dpc-826	114	20	lupus	lupus	PROPN
dpc-826	114	21	erythematosus	erythematosus	NOUN
dpc-826	114	22	associated	associate	VERB
dpc-826	114	23	with	with	ADP
dpc-826	114	24	nabpaclitaxel	nabpaclitaxel	PROPN
dpc-826	114	25	therapy	therapy	NOUN
dpc-826	114	26	.	.	PUNCT
dpc-826	115	1	curr	curr	PROPN
dpc-826	115	2	oncol	oncol	PROPN
dpc-826	115	3	2013;20(5):e484	2013;20(5):e484	NOUN
dpc-826	115	4	-	-	PUNCT
dpc-826	115	5	487	487	NUM
dpc-826	115	6	.	.	PUNCT
dpc-826	116	1	pmid	pmid	NOUN
dpc-826	116	2	:	:	PUNCT
dpc-826	116	3	24155645	24155645	NUM
dpc-826	116	4	.	.	PUNCT
dpc-826	117	1	8	8	X
dpc-826	117	2	.	.	X
dpc-826	118	1	chen	chen	PROPN
dpc-826	118	2	m	m	PROPN
dpc-826	118	3	,	,	PUNCT
dpc-826	118	4	crowson	crowson	PROPN
dpc-826	118	5	an	an	NOUN
dpc-826	118	6	,	,	PUNCT
dpc-826	118	7	woofter	woofter	AUX
dpc-826	118	8	m	m	PROPN
dpc-826	118	9	,	,	PUNCT
dpc-826	118	10	luca	luca	PROPN
dpc-826	118	11	mb	mb	PROPN
dpc-826	118	12	,	,	PUNCT
dpc-826	118	13	magro	magro	PROPN
dpc-826	118	14	cm	cm	PROPN
dpc-826	118	15	.	.	PUNCT
dpc-826	119	1	docetaxel	docetaxel	PROPN
dpc-826	119	2	(	(	PUNCT
dpc-826	119	3	taxotere	taxotere	PROPN
dpc-826	119	4	)	)	PUNCT
dpc-826	119	5	induced	induce	VERB
dpc-826	119	6	subacute	subacute	NOUN
dpc-826	119	7	cutaneous	cutaneous	ADJ
dpc-826	119	8	lupus	lupus	PROPN
dpc-826	119	9	erythematosus	erythematosus	NOUN
dpc-826	119	10	:	:	PUNCT
dpc-826	119	11	report	report	NOUN
dpc-826	119	12	of	of	ADP
dpc-826	119	13	4	4	NUM
dpc-826	119	14	cases	case	NOUN
dpc-826	119	15	.	.	PUNCT
dpc-826	120	1	j	j	PROPN
dpc-826	120	2	rheumatol	rheumatol	VERB
dpc-826	120	3	2004;31(4):818	2004;31(4):818	PROPN
dpc-826	120	4	-	-	PUNCT
dpc-826	120	5	820	820	NUM
dpc-826	120	6	.	.	PUNCT
dpc-826	121	1	pmid	pmid	NOUN
dpc-826	121	2	:	:	PUNCT
dpc-826	121	3	15088316	15088316	NUM
dpc-826	121	4	.	.	PUNCT
dpc-826	122	1	9	9	X
dpc-826	122	2	.	.	X
dpc-826	122	3	adachi	adachi	PROPN
dpc-826	122	4	a	a	PROPN
dpc-826	122	5	,	,	PUNCT
dpc-826	122	6	horikawa	horikawa	PROPN
dpc-826	122	7	t.	t.	PROPN
dpc-826	122	8	paclitaxel	paclitaxel	PROPN
dpc-826	122	9	-	-	PUNCT
dpc-826	122	10	induced	induce	VERB
dpc-826	122	11	cutaneous	cutaneous	ADJ
dpc-826	122	12	lupus	lupus	NOUN
dpc-826	122	13	erythematosus	erythematosus	NOUN
dpc-826	122	14	in	in	ADP
dpc-826	122	15	patients	patient	NOUN
dpc-826	122	16	with	with	ADP
dpc-826	122	17	derum	derum	NOUN
dpc-826	122	18	anti	anti	ADJ
dpc-826	122	19	-	-	ADJ
dpc-826	122	20	ssa	ssa	ADJ
dpc-826	122	21	/	/	SYM
dpc-826	122	22	ro	ro	X
dpc-826	122	23	antibody	antibody	NOUN
dpc-826	122	24	.	.	PUNCT
dpc-826	123	1	j	j	PROPN
dpc-826	123	2	dermatol	dermatol	NOUN
dpc-826	123	3	2007;34(7):473	2007;34(7):473	PROPN
dpc-826	123	4	-	-	SYM
dpc-826	123	5	476	476	NUM
dpc-826	123	6	.	.	PUNCT
dpc-826	124	1	pmid	pmid	NOUN
dpc-826	124	2	:	:	PUNCT
dpc-826	124	3	17584326	17584326	NUM
dpc-826	124	4	.	.	PUNCT
dpc-826	125	1	10	10	NUM
dpc-826	125	2	.	.	PUNCT
dpc-826	126	1	pham	pham	PROPN
dpc-826	126	2	aq	aq	PROPN
dpc-826	126	3	,	,	PUNCT
dpc-826	126	4	berz	berz	X
dpc-826	126	5	d	d	PROPN
dpc-826	126	6	,	,	PUNCT
dpc-826	126	7	karwan	karwan	NOUN
dpc-826	126	8	p	p	NOUN
dpc-826	126	9	,	,	PUNCT
dpc-826	126	10	colvin	colvin	PROPN
dpc-826	126	11	ga	ga	PROPN
dpc-826	126	12	.	.	PROPN
dpc-826	126	13	cremophor	cremophor	NOUN
dpc-826	126	14	-	-	PUNCT
dpc-826	126	15	induced	induce	VERB
dpc-826	126	16	lupus	lupus	NOUN
dpc-826	126	17	erythematosus	erythematosus	NOUN
dpc-826	126	18	-	-	PUNCT
dpc-826	126	19	like	like	ADJ
dpc-826	126	20	reaction	reaction	NOUN
dpc-826	126	21	with	with	ADP
dpc-826	126	22	taxol	taxol	PROPN
dpc-826	126	23	administration	administration	NOUN
dpc-826	126	24	:	:	PUNCT
dpc-826	126	25	a	a	DET
dpc-826	126	26	case	case	NOUN
dpc-826	126	27	report	report	NOUN
dpc-826	126	28	and	and	CCONJ
dpc-826	126	29	review	review	NOUN
dpc-826	126	30	of	of	ADP
dpc-826	126	31	the	the	DET
dpc-826	126	32	literature	literature	NOUN
dpc-826	126	33	.	.	PUNCT
dpc-826	127	1	case	case	NOUN
dpc-826	127	2	rep	rep	PROPN
dpc-826	127	3	oncol	oncol	ADJ
dpc-826	127	4	2011;4(3):526	2011;4(3):526	NUM
dpc-826	127	5	-	-	PUNCT
dpc-826	127	6	530	530	NUM
dpc-826	127	7	.	.	PUNCT
dpc-826	128	1	pmid	pmid	NOUN
dpc-826	128	2	:	:	PUNCT
dpc-826	128	3	22125524	22125524	NUM
dpc-826	128	4	.	.	PUNCT
dpc-826	129	1	11	11	NUM
dpc-826	129	2	.	.	X
dpc-826	130	1	dawe	dawe	PROPN
dpc-826	130	2	rs	rs	PROPN
dpc-826	130	3	,	,	PUNCT
dpc-826	130	4	ibbotson	ibbotson	PROPN
dpc-826	130	5	sh	sh	PROPN
dpc-826	130	6	.	.	PROPN
dpc-826	130	7	drug	drug	NOUN
dpc-826	130	8	-	-	PUNCT
dpc-826	130	9	induced	induce	VERB
dpc-826	130	10	photosensitivity	photosensitivity	NOUN
dpc-826	130	11	.	.	PUNCT
dpc-826	131	1	dermatol	dermatol	NOUN
dpc-826	131	2	clin	clin	PROPN
dpc-826	131	3	2014;32(3):363	2014;32(3):363	PROPN
dpc-826	131	4	-	-	PUNCT
dpc-826	131	5	368	368	NUM
dpc-826	131	6	.	.	PUNCT
dpc-826	132	1	pmid	pmid	NOUN
dpc-826	132	2	:	:	PUNCT
dpc-826	132	3	24891058	24891058	NUM
dpc-826	132	4	.	.	PUNCT
dpc-826	133	1	12	12	NUM
dpc-826	133	2	.	.	PUNCT
dpc-826	134	1	tokunaga	tokunaga	PROPN
dpc-826	134	2	m	m	PROPN
dpc-826	134	3	,	,	PUNCT
dpc-826	134	4	iga	iga	PROPN
dpc-826	134	5	n	n	CCONJ
dpc-826	134	6	,	,	PUNCT
dpc-826	134	7	endo	endo	PROPN
dpc-826	134	8	y	y	PROPN
dpc-826	134	9	,	,	PUNCT
dpc-826	134	10	et	et	PROPN
dpc-826	134	11	al	al	PROPN
dpc-826	134	12	.	.	PROPN
dpc-826	134	13	elevated	elevated	ADJ
dpc-826	134	14	protoporphyrin	protoporphyrin	NOUN
dpc-826	134	15	in	in	ADP
dpc-826	134	16	patients	patient	NOUN
dpc-826	134	17	with	with	ADP
dpc-826	134	18	skin	skin	NOUN
dpc-826	134	19	cancer	cancer	NOUN
dpc-826	134	20	receiving	receive	VERB
dpc-826	134	21	taxane	taxane	NOUN
dpc-826	134	22	chemotherapy	chemotherapy	NOUN
dpc-826	134	23	.	.	PUNCT
dpc-826	135	1	eur	eur	PROPN
dpc-826	135	2	j	j	PROPN
dpc-826	135	3	dermatol	dermatol	NOUN
dpc-826	135	4	2013;23(6):826	2013;23(6):826	NUM
dpc-826	135	5	-	-	PUNCT
dpc-826	135	6	829	829	NUM
dpc-826	135	7	.	.	PUNCT
dpc-826	136	1	pmid	pmid	NOUN
dpc-826	136	2	:	:	PUNCT
dpc-826	136	3	24480579	24480579	NUM
dpc-826	136	4	.	.	PUNCT
dpc-826	137	1	13	13	NUM
dpc-826	137	2	.	.	X
dpc-826	138	1	vihinen	vihinen	PROPN
dpc-826	138	2	p	p	NOUN
dpc-826	138	3	,	,	PUNCT
dpc-826	138	4	paija	paija	NOUN
dpc-826	138	5	o	o	NOUN
dpc-826	138	6	,	,	PUNCT
dpc-826	138	7	kivisaari	kivisaari	PROPN
dpc-826	138	8	a	a	PROPN
dpc-826	138	9	,	,	PUNCT
dpc-826	138	10	koulu	koulu	ADJ
dpc-826	138	11	l	l	NOUN
dpc-826	138	12	,	,	PUNCT
dpc-826	138	13	aho	aho	PROPN
dpc-826	138	14	h.	h.	PROPN
dpc-826	138	15	cutaneous	cutaneous	ADJ
dpc-826	138	16	lupus	lupus	PROPN
dpc-826	138	17	erythematosus	erythematosus	NOUN
dpc-826	138	18	after	after	ADP
dpc-826	138	19	treatment	treatment	NOUN
dpc-826	138	20	with	with	ADP
dpc-826	138	21	paclitaxel	paclitaxel	PROPN
dpc-826	138	22	and	and	CCONJ
dpc-826	138	23	bevacizumab	bevacizumab	NOUN
dpc-826	138	24	for	for	ADP
dpc-826	138	25	metastatic	metastatic	ADJ
dpc-826	138	26	breast	breast	NOUN
dpc-826	138	27	cancer	cancer	NOUN
dpc-826	138	28	:	:	PUNCT
dpc-826	138	29	a	a	DET
dpc-826	138	30	case	case	NOUN
dpc-826	138	31	report	report	NOUN
dpc-826	138	32	.	.	PUNCT
dpc-826	139	1	j	j	PROPN
dpc-826	139	2	med	med	PROPN
dpc-826	139	3	case	case	NOUN
dpc-826	139	4	rep	rep	PROPN
dpc-826	139	5	2011;5:243	2011;5:243	PROPN
dpc-826	139	6	.	.	PUNCT
dpc-826	140	1	pmid	pmid	NOUN
dpc-826	140	2	:	:	PUNCT
dpc-826	140	3	21707979	21707979	NUM
dpc-826	140	4	.	.	PUNCT
dpc-826	141	1	treatment	treatment	NOUN
dpc-826	141	2	of	of	ADP
dpc-826	141	3	taxane	taxane	NOUN
dpc-826	141	4	-	-	PUNCT
dpc-826	141	5	induced	induce	VERB
dpc-826	141	6	photodermatoses	photodermatose	NOUN
dpc-826	141	7	typically	typically	ADV
dpc-826	141	8	involves	involve	VERB
dpc-826	141	9	topical	topical	ADJ
dpc-826	141	10	or	or	CCONJ
dpc-826	141	11	systemic	systemic	ADJ
dpc-826	141	12	corticosteroids	corticosteroid	NOUN
dpc-826	141	13	and	and	CCONJ
dpc-826	141	14	photoprotection	photoprotection	NOUN
dpc-826	141	15	.	.	PUNCT
dpc-826	142	1	oral	oral	ADJ
dpc-826	142	2	antihistamines	antihistamine	NOUN
dpc-826	142	3	may	may	AUX
dpc-826	142	4	also	also	ADV
dpc-826	142	5	be	be	AUX
dpc-826	142	6	helpful	helpful	ADJ
dpc-826	142	7	for	for	ADP
dpc-826	142	8	some	some	DET
dpc-826	142	9	patients	patient	NOUN
dpc-826	142	10	[	[	X
dpc-826	142	11	3,13	3,13	NUM
dpc-826	142	12	]	]	PUNCT
dpc-826	142	13	.	.	PUNCT
dpc-826	143	1	the	the	DET
dpc-826	143	2	presence	presence	NOUN
dpc-826	143	3	of	of	ADP
dpc-826	143	4	a	a	DET
dpc-826	143	5	photodermatosis	photodermatosis	NOUN
dpc-826	143	6	is	be	AUX
dpc-826	143	7	not	not	PART
dpc-826	143	8	an	an	DET
dpc-826	143	9	absolute	absolute	ADJ
dpc-826	143	10	contraindication	contraindication	NOUN
dpc-826	143	11	to	to	ADP
dpc-826	143	12	continuing	continue	VERB
dpc-826	143	13	chemotherapy	chemotherapy	NOUN
dpc-826	143	14	,	,	PUNCT
dpc-826	143	15	especially	especially	ADV
dpc-826	143	16	with	with	ADP
dpc-826	143	17	strict	strict	ADJ
dpc-826	143	18	avoidance	avoidance	NOUN
dpc-826	143	19	of	of	ADP
dpc-826	143	20	sun	sun	NOUN
dpc-826	143	21	exposure	exposure	NOUN
dpc-826	143	22	.	.	PUNCT
dpc-826	144	1	however	however	ADV
dpc-826	144	2	,	,	PUNCT
dpc-826	144	3	withdrawal	withdrawal	NOUN
dpc-826	144	4	of	of	ADP
dpc-826	144	5	the	the	DET
dpc-826	144	6	drug	drug	NOUN
dpc-826	144	7	may	may	AUX
dpc-826	144	8	be	be	AUX
dpc-826	144	9	required	require	VERB
dpc-826	144	10	if	if	SCONJ
dpc-826	144	11	the	the	DET
dpc-826	144	12	cutaneous	cutaneous	ADJ
dpc-826	144	13	reaction	reaction	NOUN
dpc-826	144	14	is	be	AUX
dpc-826	144	15	severe	severe	ADJ
dpc-826	144	16	or	or	CCONJ
dpc-826	144	17	if	if	SCONJ
dpc-826	144	18	the	the	DET
dpc-826	144	19	lesions	lesion	NOUN
dpc-826	144	20	fail	fail	VERB
dpc-826	144	21	to	to	PART
dpc-826	144	22	resolve	resolve	VERB
dpc-826	144	23	with	with	ADP
dpc-826	144	24	conservative	conservative	ADJ
dpc-826	144	25	treatment	treatment	NOUN
dpc-826	144	26	.	.	PUNCT
dpc-826	145	1	conclusion	conclusion	NOUN
dpc-826	145	2	taxanes	taxane	NOUN
dpc-826	145	3	are	be	AUX
dpc-826	145	4	chemotherapeutic	chemotherapeutic	ADJ
dpc-826	145	5	agents	agent	NOUN
dpc-826	145	6	used	use	VERB
dpc-826	145	7	in	in	ADP
dpc-826	145	8	the	the	DET
dpc-826	145	9	management	management	NOUN
dpc-826	145	10	of	of	ADP
dpc-826	145	11	various	various	ADJ
dpc-826	145	12	neoplasms	neoplasm	NOUN
dpc-826	145	13	.	.	PUNCT
dpc-826	146	1	paclitaxel	paclitaxel	PROPN
dpc-826	146	2	and	and	CCONJ
dpc-826	146	3	nab	nab	NOUN
dpc-826	146	4	-	-	PUNCT
dpc-826	146	5	paclitaxel	paclitaxel	PROPN
dpc-826	146	6	are	be	AUX
dpc-826	146	7	taxanes	taxane	NOUN
dpc-826	146	8	that	that	PRON
dpc-826	146	9	have	have	AUX
dpc-826	146	10	been	be	AUX
dpc-826	146	11	associated	associate	VERB
dpc-826	146	12	with	with	ADP
dpc-826	146	13	photodermatoses	photodermatose	NOUN
dpc-826	146	14	,	,	PUNCT
dpc-826	146	15	including	include	VERB
dpc-826	146	16	erythema	erythema	ADJ
dpc-826	146	17	multiforme	multiforme	NOUN
dpc-826	146	18	,	,	PUNCT
dpc-826	146	19	onycholysis	onycholysis	NOUN
dpc-826	146	20	,	,	PUNCT
dpc-826	146	21	photo	photo	NOUN
dpc-826	146	22	recall	recall	NOUN
dpc-826	146	23	phenomenon	phenomenon	NOUN
dpc-826	146	24	,	,	PUNCT
dpc-826	146	25	and	and	CCONJ
dpc-826	146	26	subacute	subacute	VERB
dpc-826	146	27	cutaneous	cutaneous	ADJ
dpc-826	146	28	lupus	lupus	PROPN
dpc-826	146	29	erythematosus	erythematosus	PROPN
dpc-826	146	30	.	.	PUNCT
dpc-826	147	1	the	the	DET
dpc-826	147	2	incidence	incidence	NOUN
dpc-826	147	3	of	of	ADP
dpc-826	147	4	photodermatoses	photodermatose	NOUN
dpc-826	147	5	secondary	secondary	ADJ
dpc-826	147	6	to	to	ADP
dpc-826	147	7	paclitaxel	paclitaxel	PROPN
dpc-826	147	8	or	or	CCONJ
dpc-826	147	9	nab	nab	VERB
dpc-826	147	10	-	-	PUNCT
dpc-826	147	11	paclitaxel	paclitaxel	PROPN
dpc-826	147	12	may	may	AUX
dpc-826	147	13	be	be	AUX
dpc-826	147	14	higher	high	ADJ
dpc-826	147	15	than	than	SCONJ
dpc-826	147	16	the	the	DET
dpc-826	147	17	published	publish	VERB
dpc-826	147	18	literature	literature	NOUN
dpc-826	147	19	reflects	reflect	VERB
dpc-826	147	20	.	.	PUNCT
dpc-826	148	1	the	the	DET
dpc-826	148	2	development	development	NOUN
dpc-826	148	3	of	of	ADP
dpc-826	148	4	symptoms	symptom	NOUN
dpc-826	148	5	and/or	and/or	CCONJ
dpc-826	148	6	skin	skin	NOUN
dpc-826	148	7	lesions	lesion	NOUN
dpc-826	148	8	on	on	ADP
dpc-826	148	9	sun	sun	NOUN
dpc-826	148	10	-	-	PUNCT
dpc-826	148	11	exposed	expose	VERB
dpc-826	148	12	areas	area	NOUN
dpc-826	148	13	in	in	ADP
dpc-826	148	14	patients	patient	NOUN
dpc-826	148	15	receiving	receive	VERB
dpc-826	148	16	these	these	DET
dpc-826	148	17	agents	agent	NOUN
dpc-826	148	18	should	should	AUX
dpc-826	148	19	prompt	prompt	VERB
dpc-826	148	20	the	the	DET
dpc-826	148	21	clinician	clinician	NOUN
dpc-826	148	22	to	to	PART
dpc-826	148	23	evaluate	evaluate	VERB
dpc-826	148	24	the	the	DET
dpc-826	148	25	patient	patient	NOUN
dpc-826	148	26	for	for	ADP
dpc-826	148	27	a	a	DET
dpc-826	148	28	drug	drug	NOUN
dpc-826	148	29	-	-	PUNCT
dpc-826	148	30	related	relate	VERB
dpc-826	148	31	photodermatosis	photodermatosis	NOUN
dpc-826	148	32	.	.	PUNCT
dpc-826	149	1	evaluation	evaluation	NOUN
dpc-826	149	2	could	could	AUX
dpc-826	149	3	include	include	VERB
dpc-826	149	4	serologic	serologic	NOUN
dpc-826	149	5	tests	test	NOUN
dpc-826	149	6	(	(	PUNCT
dpc-826	149	7	to	to	PART
dpc-826	149	8	evaluate	evaluate	VERB
dpc-826	149	9	for	for	ADP
dpc-826	149	10	lupus	lupus	ADJ
dpc-826	149	11	erythematosus	erythematosus	NOUN
dpc-826	149	12	and	and	CCONJ
dpc-826	149	13	porphyria	porphyria	NOUN
dpc-826	149	14	)	)	PUNCT
dpc-826	149	15	and	and	CCONJ
dpc-826	149	16	tissue	tissue	NOUN
dpc-826	149	17	biopsy	biopsy	NOUN
dpc-826	149	18	for	for	ADP
dpc-826	149	19	microscopic	microscopic	ADJ
dpc-826	149	20	examination	examination	NOUN
dpc-826	149	21	.	.	PUNCT
dpc-826	150	1	strict	strict	ADJ
dpc-826	150	2	adherence	adherence	NOUN
dpc-826	150	3	to	to	ADP
dpc-826	150	4	avoiding	avoid	VERB
dpc-826	150	5	exposure	exposure	NOUN
dpc-826	150	6	to	to	ADP
dpc-826	150	7	sunlight	sunlight	NOUN
dpc-826	150	8	should	should	AUX
dpc-826	150	9	be	be	AUX
dpc-826	150	10	initiated	initiate	VERB
dpc-826	150	11	.	.	PUNCT
dpc-826	151	1	symptomatic	symptomatic	ADJ
dpc-826	151	2	treatments	treatment	NOUN
dpc-826	151	3	with	with	ADP
dpc-826	151	4	topical	topical	ADJ
dpc-826	151	5	or	or	CCONJ
dpc-826	151	6	,	,	PUNCT
dpc-826	151	7	if	if	SCONJ
dpc-826	151	8	necessary	necessary	ADJ
dpc-826	151	9	,	,	PUNCT
dpc-826	151	10	systemic	systemic	ADJ
dpc-826	151	11	corticosteroids	corticosteroid	NOUN
dpc-826	151	12	should	should	AUX
dpc-826	151	13	also	also	ADV
dpc-826	151	14	be	be	AUX
dpc-826	151	15	considered	consider	VERB
dpc-826	151	16	.	.	PUNCT
dpc-826	152	1	the	the	DET
dpc-826	152	2	development	development	NOUN
dpc-826	152	3	of	of	ADP
dpc-826	152	4	a	a	DET
dpc-826	152	5	taxane	taxane	NOUN
dpc-826	152	6	-	-	PUNCT
dpc-826	152	7	associated	associate	VERB
dpc-826	152	8	photodermatosis	photodermatosis	NOUN
dpc-826	152	9	is	be	AUX
dpc-826	152	10	not	not	PART
dpc-826	152	11	an	an	DET
dpc-826	152	12	absolute	absolute	ADJ
dpc-826	152	13	contraindication	contraindication	NOUN
dpc-826	152	14	to	to	ADP
dpc-826	152	15	continuing	continue	VERB
dpc-826	152	16	treatment	treatment	NOUN
dpc-826	152	17	with	with	ADP
dpc-826	152	18	the	the	DET
dpc-826	152	19	drug	drug	NOUN
dpc-826	152	20	.	.	PUNCT
dpc-826	153	1	however	however	ADV
dpc-826	153	2	,	,	PUNCT
dpc-826	153	3	limited	limited	ADJ
dpc-826	153	4	exposure	exposure	NOUN
dpc-826	153	5	to	to	ADP
dpc-826	153	6	ultraviolet	ultraviolet	ADJ
dpc-826	153	7	radiation	radiation	NOUN
dpc-826	153	8	is	be	AUX
dpc-826	153	9	recommended	recommend	VERB
dpc-826	153	10	.	.	PUNCT
dpc-826	154	1	references	reference	NOUN
dpc-826	154	2	1	1	NUM
dpc-826	154	3	.	.	PUNCT
dpc-826	154	4	cohen	cohen	PROPN
dpc-826	154	5	pr	pr	PROPN
dpc-826	154	6	.	.	PUNCT
dpc-826	155	1	photodistributed	photodistribute	VERB
dpc-826	155	2	erythema	erythema	ADJ
dpc-826	155	3	multiforme	multiforme	NOUN
dpc-826	155	4	:	:	PUNCT
dpc-826	155	5	paclitaxeltable	paclitaxeltable	ADJ
dpc-826	155	6	1	1	NUM
dpc-826	155	7	.	.	PUNCT
dpc-826	155	8	drug	drug	NOUN
dpc-826	155	9	-	-	PUNCT
dpc-826	155	10	induced	induce	VERB
dpc-826	155	11	photosensitivity	photosensitivity	NOUN
dpc-826	155	12	:	:	PUNCT
dpc-826	155	13	phototoxicity	phototoxicity	NOUN
dpc-826	155	14	versus	versus	ADP
dpc-826	155	15	photoallergy	photoallergy	NOUN
dpc-826	155	16	phototoxicity	phototoxicity	NOUN
dpc-826	155	17	photoallergy	photoallergy	NOUN
dpc-826	155	18	incidence	incidence	VERB
dpc-826	155	19	common	common	ADJ
dpc-826	155	20	rare	rare	ADJ
dpc-826	155	21	appearance	appearance	NOUN
dpc-826	155	22	sunburn	sunburn	NOUN
dpc-826	155	23	-	-	PUNCT
dpc-826	155	24	like	like	ADJ
dpc-826	155	25	appearance	appearance	NOUN
dpc-826	155	26	with	with	ADP
dpc-826	155	27	erythema	erythema	ADJ
dpc-826	155	28	and/or	and/or	CCONJ
dpc-826	155	29	edema	edema	PROPN
dpc-826	155	30	dermatitis	dermatitis	NOUN
dpc-826	155	31	onset	onset	VERB
dpc-826	155	32	immediately	immediately	ADV
dpc-826	155	33	after	after	ADP
dpc-826	155	34	exposure	exposure	NOUN
dpc-826	155	35	to	to	ADP
dpc-826	155	36	sunlight	sunlight	NOUN
dpc-826	155	37	24	24	NUM
dpc-826	155	38	-	-	SYM
dpc-826	155	39	72	72	NUM
dpc-826	155	40	hours	hour	NOUN
dpc-826	155	41	after	after	ADP
dpc-826	155	42	exposure	exposure	NOUN
dpc-826	155	43	to	to	ADP
dpc-826	155	44	sunlight	sunlight	NOUN
dpc-826	155	45	required	require	VERB
dpc-826	155	46	dose	dose	NOUN
dpc-826	155	47	of	of	ADP
dpc-826	155	48	uv	uv	NOUN
dpc-826	155	49	radiation	radiation	NOUN
dpc-826	155	50	moderate	moderate	ADJ
dpc-826	155	51	-	-	PUNCT
dpc-826	155	52	high	high	ADJ
dpc-826	155	53	low	low	ADJ
dpc-826	155	54	required	require	VERB
dpc-826	155	55	dose	dose	NOUN
dpc-826	155	56	of	of	ADP
dpc-826	155	57	drug	drug	NOUN
dpc-826	155	58	moderate	moderate	ADJ
dpc-826	155	59	-	-	PUNCT
dpc-826	155	60	high	high	ADJ
dpc-826	155	61	low	low	ADJ
dpc-826	155	62	areas	area	NOUN
dpc-826	155	63	affected	affect	VERB
dpc-826	155	64	sun	sun	NOUN
dpc-826	155	65	-	-	PUNCT
dpc-826	155	66	exposed	expose	VERB
dpc-826	155	67	areas	area	NOUN
dpc-826	155	68	only	only	ADV
dpc-826	155	69	initially	initially	ADV
dpc-826	155	70	sun	sun	NOUN
dpc-826	155	71	-	-	PUNCT
dpc-826	155	72	exposed	expose	VERB
dpc-826	155	73	areas	area	NOUN
dpc-826	155	74	and	and	CCONJ
dpc-826	155	75	may	may	AUX
dpc-826	155	76	spread	spread	VERB
dpc-826	155	77	to	to	ADP
dpc-826	155	78	photoprotected	photoprotecte	VERB
dpc-826	155	79	areas	area	NOUN
dpc-826	155	80	pathophysiology	pathophysiology	NOUN
dpc-826	155	81	tissue	tissue	NOUN
dpc-826	155	82	injury	injury	NOUN
dpc-826	155	83	cell	cell	NOUN
dpc-826	155	84	-	-	PUNCT
dpc-826	155	85	mediated	mediate	VERB
dpc-826	155	86	immune	immune	ADJ
dpc-826	155	87	response	response	NOUN